vancomycin has been researched along with Antibiotic-Associated Colitis in 537 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 146 (27.19) | 18.7374 |
1990's | 71 (13.22) | 18.2507 |
2000's | 121 (22.53) | 29.6817 |
2010's | 191 (35.57) | 24.3611 |
2020's | 8 (1.49) | 2.80 |
Authors | Studies |
---|---|
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
Cloud, JW; Espinoza, D; Kelly, CP; Kokkotou, E; Michos, A; Moss, AC; Mustafa, N; O'Brien, M; Pothoulakis, C | 1 |
Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
Babakhani, F; Robert, N; Sears, P; Seddon, J; Shue, YK | 1 |
Amaral, A; Brewer, JT; Bushell, SM; Deng, G; Dewhurst, JM; Ding, J; Dzink-Fox, J; Gamber, G; Jain, A; LaMarche, MJ; Lee, K; Lee, L; Leeds, JA; Lister, T; McKenney, D; Mullin, S; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Sachdeva, M; Shao, J; Tiamfook, S; Trzasko, A; Whitehead, L; Yan, W; Yifru, A; Yu, D; Zhu, Q | 1 |
Citron, D; He, Y; Herradura, P; Howland, K; Keith, D; Li, J; Mascio, CT; Mesleh, MF; Metcalf, C; Mortin, LI; Pearson, A; Silverman, J; Steenbergen, J; Thorne, GM; Van Praagh, AD; Yin, N | 1 |
Stephenson, AL | 1 |
Dai, J; Gong, J; Guo, R | 1 |
Bowman, JA; Utter, GH | 1 |
Quigley, EMM | 1 |
Bai, Y; Huang, GQ; Liu, J; Sun, ZQ | 1 |
AbdelKhalek, A; Seleem, MN | 1 |
Baiu, I; Forgó, E; Kin, C; Weiser, TG | 1 |
Bidell, MR; Bratek, BR; Duru, OO; Mitchell, CL; Novak, GM; O'Donnell, JN; Roddy, KM; Singh, G | 1 |
Benea, SN; Hristea, A; Jipa, RE; Manea, E; Rodríguez-Baño, J; Sojo-Dorado, J | 1 |
Baharith, H; Ford, AC; Moayyedi, P; Yuan, Y | 1 |
Ariyoshi, N; Fujishiro, T; Hattori, N; Ishii, I; Ishikawa, M; Matsubara, H; Miyauchi, H; Oami, T; Oda, S; Suzuki, T; Takatsuka, H; Yamazaki, S | 1 |
Adomakoh, N; Aguado, JM; Anttila, VJ; Bisnauthsing, K; Cornely, OA; Georgopali, A; Goldenberg, SD; Guery, B; Karas, A; Kazeem, G; Longshaw, C; Menichetti, F; Palacios-Fabrega, JA; Vehreschild, MJGT | 1 |
Chen, X; Faull, KF; Ghali, S; Jacobs, JP; Koon, HW; Lagishetty, V; Lee, EC; Moller, T; Mussatto, CC; Ortiz, C; Rossetti, M; Tran, DH; Wang, J; Xu, C | 1 |
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L | 1 |
Abe, K; Furukawa, K; Ishida, Y; Sakamoto, T; Shiba, H; Yanaga, K | 1 |
Dow, DE; Seed, PC | 1 |
Cammarota, G; Gasbarrini, A; Ianiro, G; Lopetuso, LR; Masucci, L; Quaranta, G; Sanguinetti, M; Simonelli, C | 1 |
Mullish, BH; Williams, HR | 1 |
Boulos, RA; Pagano, P; Pillar, CM; Shinabarger, DL; Wolfe, C | 1 |
Ip, M; Jiang, M; Leung, NH; You, JHS | 1 |
Kodadek, LM; Lipsett, PA | 1 |
Gandhi, S; Patel, D; Sohal, S | 1 |
Alireza Taghavi, S; Amanati, A; Bazargani, A; Heidari, H; Kalantar, K; Motamedifar, M; Nikokar, I; Sedigh Ebrahim-Saraie, H | 1 |
Ramesh, MS; Yee, J | 1 |
Fang, Z; Jiang, M; Liu, Y; Lv, X; Ren, W; Zhang, J | 1 |
Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH | 1 |
Bateman, BT; Bykov, K; Choudhry, NK; Fischer, MA; Franklin, JM; Gagne, JJ; Kulik, A; Liu, J; Polinski, JM; Rassen, JA; Schneeweiss, S | 1 |
Ahmad, S; Boothe, H; Cohen, HW; Coyle, C; Feinberg, EJ; Huh, HC; Kim, PK; Teperman, S | 1 |
Cotter, PD; Hill, C; Mathur, H; O'Connor, PM; Ross, RP | 1 |
Buppajarntham, S; Junpaparp, P; Madueno, FV; Varadi, G | 1 |
Neurath, MF; Strauss, R | 1 |
Cornely, OA; Fantin, B; Gorbach, S; Kean, Y; Miller, MA; Mullane, K | 1 |
Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E | 2 |
Cornely, OA; Crook, DW; Golan, Y; Gorbach, SL; Josephson, MA; Louie, TJ; Miller, MA; Mullane, KM | 1 |
Bhatt, V; Parmar, SR; Schuster, M; Yang, J; Zhang, Q | 1 |
Clutter, DS; Dubrovskaya, Y; Merl, MY; Press, R; Safdar, A; Teperman, L | 1 |
Hung, YP; Ko, WC; Lee, CI; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wan, L; Wu, TC; Wu, YH | 1 |
Kılıç, A | 1 |
de Vrieze, J | 1 |
Cui, E; Eells, SJ; Huang, SS; McKinnell, JA; Miller, LG | 1 |
Anttila, VJ; Arkkila, P; Mattila, E | 1 |
Ebigbo, A; Messmann, H | 1 |
Patel, LN; Schairer, J; Shen, B | 1 |
John, E; Lippmann, N; Lübbert, C; Mössner, J; Weis, S | 1 |
Causey, MW; Cummings, M; Johnson, EK; Maykel, JA; Steele, S; Walker, A | 1 |
Cornely, OA; Fantin, BR; Gorbach, SL; Kean, Y; Miller, MA; Mullane, KM | 1 |
Acharya, UH; Green, MR; Yeager, AM | 1 |
Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A | 1 |
Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P | 1 |
García-Bujalance, S; Muñoz-Vélez, M | 1 |
Shafran, DM; Shafran, SD | 1 |
Farrell, MS; Marien, B; Schiowitz, MF | 1 |
Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N | 1 |
Araki, K; Goto, H; Kikuchi, K; Koide, T; Makino, H; Ogawa, Y; Ohkuma, K; Saraya, T; Takizawa, H; Yonetani, S | 1 |
Enser, JJ; Hess, TM; Hsu, JL; Leverson, GE; McKown, T; Pirsch, JD; Safdar, N | 1 |
Kleger, A; Nitschmann, S; Seufferlein, T | 1 |
Wilcox, MH | 3 |
Smith, S | 1 |
Katzianer, DS; Rubin, H; Yano, T; Zhu, J | 1 |
Binion, DG; Hashash, JG | 1 |
Chen, X; Cheng, M; Hing, TC; Ho, S; Ichikawa, Y; Kelly, CP; Koon, HW; Pothoulakis, C | 1 |
Estes, L; Khanna, S; Pardi, D; Saffouri, G | 1 |
Sullivan, T | 1 |
Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
Cornely, OA; Ivanescu, C; Nathwani, D; Odeyemi, IA; Odufowora-Sita, O; Retsa, P | 1 |
Alagoz, O; Codella, J; Heffernan, R; Safdar, N | 1 |
Balzola Regout, B; Ezpeleta Lobato, G; Loizaga Díaz, I; Vilella Ciriza, ML | 1 |
Adamson, WT; Erickson, KM; McLean, SE; Phillips, MR | 1 |
de Castro, CG; Ganc, AJ; Ganc, RL; Hamerschlack, N; Petrolli, MS | 1 |
Beamer, G; Kim, HB; Sun, X; Tzipori, S; Wang, Y; Zhang, Q | 1 |
Belyaev, O; Chromik, AM; Deleites, C; Herzog, T; Uhl, W | 1 |
Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M | 1 |
Bassis, CM; Schumacher, CA; Seekatz, AM; Theriot, CM; Young, VB | 1 |
Keller, JJ; Kuijper, EJ | 1 |
Christenson, ES; Hsu, S; Ligon, C | 1 |
Joundi, RA; Leis, JA; Wong, BM | 1 |
Bibbò, S; Cammarota, G; Costamagna, G; Dinoi, G; Gasbarrini, A; Ianiro, G; Masucci, L; Sanguinetti, M | 1 |
Biltaji, E; Kyle Jensen, M; LaFleur, J; Nelson, RE; Roberts, MS; Smith, KJ; Varier, RU | 1 |
Chiueh, TS; Huang, ZY; Lai, MJ; Lin, JC | 1 |
Liu, W; Lv, Z; Peng, G; Su, J; Xu, H | 1 |
Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N | 1 |
Barbut, F; Blais, L; Hirschel, B; Khanafer, N; Vanhems, P | 1 |
Ananthakrishnan, AN; Barber, GE; Wen, J | 1 |
Aldrete, Sdel M; Banks, GG; Burd, EM; Chan, AW; Friedman-Moraco, RJ; Kraft, CS; Magee, MJ | 1 |
Beardsley, JR; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC | 1 |
Demura, K; Imagawa, A; Kameyama, M; Kawasaki, M; Mizumura, N; Ogawa, M; Ohba, K; Okumura, S; Toyoda, S | 1 |
Marra, F; Ng, K | 1 |
Bellolio, F; Castillo, R; Manterola, C; Molina, ME; Quezada, F; Urrejola, G; Villalón, C; Zúñiga, JM | 1 |
Choudhry, SZ; Kashat, M; Lim, HW | 1 |
Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C | 1 |
Greenberg, A; Matta, SK; Singh, A | 1 |
Delaune, A; Euler, CW; Fischetti, VA; Wang, Q | 1 |
Li, R; Lin, Y; Liu, X; Lu, L; Wang, M | 1 |
Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
Ishimaru, T; Koga, T; Sawayama, Y; Takeda, R | 1 |
Abou Chakra, CN; Marcil-Héguy, A; Nault, V; Pépin, J; Sheitoyan-Pesant, C; Valiquette, L | 1 |
Housman, ST; Kuti, JL; Nicolau, DP; Quintiliani, R; Thabit, AK | 1 |
Marimuthu, K; Ochi, H; Young, BE | 1 |
Beardsley, JR; Gibbs, HG; Johnson, JW; Luther, VP; Ohl, CA; Rokas, KE; Williamson, JC | 1 |
Bernard, S; Block, BL; Schwartzstein, RM | 1 |
Chilton, CH; Crowther, GS; Ewin, D; Karas, A; Longshaw, C; Todhunter, SL; Vernon, J; Wilcox, MH | 1 |
Shah, KJ; Tarasiuk-Rusek, A | 1 |
Holroyd, KB; Pahwa, A; Rittenberg, A | 1 |
Brain, D; Connelly, LB; Graves, N; Merlo, G | 1 |
Baloun, B; Gilbert, J; Nelson, C; Wiedel, N | 1 |
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T | 1 |
Hill, E; Pressly, KB; Shah, KJ | 1 |
Beneš, J; Polívková, S | 1 |
Akamine, CM; Ing, MB; Jackson, CS; Loo, LK | 1 |
Telekes, A | 1 |
Winn, R; Zhu, KJ | 1 |
Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K | 1 |
Stallmach, A | 1 |
Coburn, B; Guttman, DS; Hota, SS; Low, DE; McGeer, A; Poutanen, SM; Sales, V; Salpeter, MJ; Tomlinson, G | 1 |
Baro, E; Denies, F; Dervaux, B; Galperine, T; Guery, B; Lannoy, D; Lenne, X; Odou, P | 1 |
Hermsen, ED; Meza, JL; Njoku, JC; Olsen, KM; Qiu, F; Rupp, ME; Van Schooneveld, TC | 1 |
Banaei, N; Deresinski, S; Gombar, S; Holubar, M; Madison, A; Schroeder, LF; Shah, N; Shepard, J; Sundararajan, G; Tekic, N; Tompkins, L; Truong, CY; Wilson, R | 1 |
Evans, CT; Nelson, RL; Suda, KJ | 1 |
Estes, LL; Harmsen, WS; Nyre, LM; Orenstein, R; Patel, R; Schleck, CD; Verdoorn, BP; Wendt, RF; Wilson, JW | 1 |
Cima, RR; Selvasekar, CR; Yafi, FA | 1 |
Barker, HC; Bilton, D; Haworth, CS; Roberts, P; Williams, D | 1 |
Baines, SD; Freeman, J; O'Connor, R; Wilcox, MH | 1 |
Kaka, AS; Osawa, R | 1 |
Calfee, DP | 1 |
Baines, SD; Freeman, J; O'Connor, R; Saxton, K; Wilcox, MH | 1 |
Fujimoto, Y; Ishida, Y; Konishi, H; Kowata, S; Morimoto, Y; Nomura, K; Ohshiro, M; Oyake, T; Sato, K; Taniwaki, M; Yamashita, M; Yoshikawa, T | 1 |
Burman, LG | 1 |
Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE | 1 |
Cheknis, A; Chen, X; Gerding, DN; Goldsmith, JD; Katchar, K; Kelly, CP; Nanthakumar, N | 1 |
Prassler, R | 1 |
Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
Al-Nassir, WN; Donskey, CJ; Nerandzic, MM; Sethi, AK | 1 |
Dubberke, ER; Riddle, DJ | 2 |
Fitzpatrick, F | 1 |
Bressler, AM; Johnson, DP; Logan, N; Musher, DM; Rossignol, JF | 1 |
Bujanda, L; Cosme, A | 1 |
Kelly, CP | 2 |
Gould, FK; Hames, A; Perry, JD | 1 |
Bell, SJ; Critchley, IA; Hoang, T; Janjic, N; O'Leary, AL; Ochsner, UA; Stone, KC; Young, CL | 1 |
Altman, A; Paz, Z | 1 |
Johnson, S | 3 |
Shen, B; Wang, Y | 1 |
Chandok, N; Kamath, PS | 1 |
DePestel, DD; Frame, DG; Kaul, DR; Khaled, Y; Pogue, JM | 1 |
Gerding, DN; Hecht, DW; Johnson, S; Patel, T; Patel, U; Schriever, C | 1 |
Bakken, JS | 1 |
Bartlett, JG | 7 |
Ariyoshi, N; Harigaya, K; Hattori, N; Kitada, M; Miura, G; Nakamura, H; Nakasa, H; Oda, S; Sadahiro, T; Shinozaki, K; Toyoda, A; Yamagata, S; Yamazaki, S | 1 |
Scheppach, W | 1 |
Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Nerandzic, MM; Sethi, AK | 1 |
Causey, MW; Spencer, MP; Steele, SR | 1 |
Ambrosino, DM; Baxter, R; Blair, BM; Gerding, DN; Hay, CA; Leav, BA; Leney, M; Lowy, I; Molrine, DC; Nichol, G; Sloan, S; Thomas, WD | 1 |
Barbut, F; Eckert, C | 1 |
Nübel, U; Witte, W; Zaiss, NH | 1 |
Poxton, IR | 1 |
Chang, JH; Cho, HS; Cho, YK; Choi, MG; Chung, IS; Jung, WR; Kim, SW; Lee, YJ; Lim, CH; Nam, KW; Park, JM; Sung, HY | 1 |
Gagandeep, D; Ira, S | 1 |
Shaw, W | 1 |
Bernard, L; Grima, D; Miller, M; Pepin, J; Thompson, M | 1 |
Carroll, NV; Harpe, SE; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
Iwasaka, T; Morimoto, S; Morita, T; Seo, M; Takahashi, N | 1 |
Simor, AE | 1 |
Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS | 1 |
Hsueh, PR; Huang, YT; Ko, WC; Lee, NY | 1 |
Salkind, AR | 1 |
Antoniadou, A; Armaganidis, A; Dimopoulou, I; Kopterides, P; Papadomichelakis, E; Papageorgiou, C; Tsangaris, I | 1 |
Chihara, S; Furukata, S; Hoshino, K; Shimizu, R | 1 |
Hasuo, K; Hayashi, S; Hayashi, T; Jin, Y; Masuda, M; Rino, Y; Sawazaki, S; Suzuki, H; Tsuchida, K | 1 |
Al-Mufarrej, F; Gharagozloo, F; Margolis, M; Strother, E; Tempesta, B | 1 |
Gerding, DN; Johnson, S | 2 |
Ananthakrishnan, AN | 1 |
Chapnick, E; Kupfer, Y; Pagala, M; Rao, S; Tessler, S | 1 |
Dolgin, E | 1 |
Buckeridge, DL; Goldberg, P; Gursahaney, A; Hanley, J; Loo, V; Teltsch, DY | 1 |
Golan, Y; Gorbach, S; Lentnek, A; Louie, TJ; Miller, MA; Mullane, KM; Sears, P; Shue, YK; Weiss, K | 1 |
Studemeister, A | 1 |
Cohen, MB; Hart, KW; Lindsell, CJ; Mann, EA; Mezoff, E | 1 |
Alexander, J; Surawicz, CM | 1 |
Chang, S; Donskey, C; Dumford, DM; Nerandzic, M; Richmond, MA | 1 |
Amoros, F; Borrás-Blasco, J; Enriquez, R; Navarro-Ruiz, A; Padilla, S; Sirvent, AE; Solavera, J | 1 |
Chen, K; Davis, B; Feng, H; Sun, X; Wang, H; Zhang, Y | 1 |
Choi, HK; Kim, KH; Lee, SH; Lee, SJ | 1 |
Álvarez-Argüelles, H; Brito, ML; González-Brito, G; Hernández-Nieto, L; Lakhwani, S; Raya, JM | 1 |
Golan, Y; Gorbach, SL; Lentnek, A; Louie, TJ; Miller, MA; Mullane, KM; Sears, PS; Shue, YK; Weiss, K | 1 |
Babakhani, F; Citron, DM; Gerding, DN; Goldstein, EJ; Sambol, SP; Sears, P | 1 |
Alverdy, JC; Hall, DE; Neal, MD; Simmons, RL; Zuckerbraun, BS | 1 |
Callery, S; Daneman, N; Manek, K; Williams, V | 1 |
Amundson, WH; Decarolis, DD; Drekonja, DM; Johnson, JR; Kuskowski, MA; Lederle, FA | 1 |
Gardner, E; Mancuso, P; Meghani, N; Thomson, A | 1 |
Kang, JO; Kim, J; Pai, H; Seo, MR | 1 |
Deshpande, A; Minocha, A; Pant, C; Sferra, TJ | 1 |
Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA | 1 |
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL | 1 |
Brown, NC; Dvoskin, S; Wright, GE; Xu, WC; Yanachkov, IB; Yanachkova, M | 1 |
Allerberger, F; Kuo, HW; Laferl, H; Michl, V; Schmid, D; Tesik, P; Tucek, G; Wenisch, C; Wenisch, JM | 1 |
Kee, VR | 1 |
Cornely, OA; Crook, DW; Esposito, R; Gorbach, S; Poirier, A; Sears, P; Somero, MS; Weiss, K | 1 |
Arora, V; Garey, KW; Le, F; Palmer, HR; Salazar, M; Shah, DN | 1 |
Aroniadis, OC; Brandt, LJ; Kanatzar, A; Kelly, C; Mellow, M; Park, T; Rohlke, F; Stollman, N; Surawicz, C | 1 |
Cadnum, JL; Donskey, CJ; Eckart, KE; Nerandzic, MM | 1 |
Armbruster, S; Goldkind, L | 1 |
Gerding, DN; Gorbach, SL; Johnson, S; Louie, TJ; Ruiz, NM | 1 |
Lamarche, MJ; Leeds, JA; McKenney, D; Praestgaard, J; Trzasko, A | 1 |
Bowlin, TL; Butler, MM; Citron, DM; Dvoskin, S; Feng, H; Kelly, CP; Shinabarger, DL; Tzipori, S; Wright, GE | 1 |
Bubenik, S; Heineman, J; Martindale, R; McClave, S | 1 |
Arya, A; Chuong, CL; Howland, KT; Kang, C; Li, T; Mascio, CT; Mortin, LI; Silverman, JA; Van Praagh, AD; Zhang, S | 1 |
Gerding, DN; Monnot-Chase, E; Seiberling, M; Tatarowicz, W; Villano, SA | 1 |
Aoki, T; Fujiwara, M; Fukuzawa, M; Harada, A; Hayama, Y; Kataoka, M; Kawai, T; Kawakami, K; Moriyasu, F; Naitou, S; Nonaka, M; Sou, Y; Sugimoto, H; Takeuchi, M; Tsuji, Y; Yagi, K; Yamamoto, K | 1 |
Barman, TK; Bhati, A; Bhatnagar, PK; Chakrabarti, A; Das, B; Kalia, V; Kumar, M; Mathur, T; Pandya, M; Raj, VS; Ramkumar, G; Shukla, G; Upadhyay, DJ; Vaishnavi, C | 1 |
Carchman, EH; Nassour, I; Simmons, RL; Zuckerbraun, BS | 1 |
Kim, SW | 1 |
Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L | 1 |
Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P | 1 |
Ha, D; Tsai, CJ | 1 |
Brandt, C; Clare, S; Clark, TG; Connor, TR; Deakin, LJ; Dougan, G; Duncan, SH; Flint, HJ; Goulding, D; Lawley, TD; Parkhill, J; Pickard, DJ; Rad, R; Raisen, C; Schreiber, F; Stares, MD; Walker, AW | 1 |
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B | 1 |
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
Mehta, J; Pi, J; Trifilio, SM | 1 |
Arzese, A; Bassetti, M; Pecori, D; Villa, G; Wilcox, M | 1 |
Elmer, GW; McFarland, LV; Surawicz, CM | 1 |
Apisarnthanarak, A; Mundy, LM; Razavi, B | 1 |
Alcázar Montero, MS; Gimeno Aranguez, M; Navarro Gaspar, C; Vilalta Castel, E | 1 |
Lenzen-Grossimlinghaus, R; Strohmeyer, G | 1 |
Chang, KH; Chong, Y; Kim, JM; Kim, MS; Lee, K; Shin, JW; Yong, D | 1 |
Tanaka, K; Watanabe, K | 1 |
Akishita, M; Mizukawa, S; Ohni, M; Sudoh, N; Sugiyama, Y; Toba, K | 1 |
Cirocco, WC | 1 |
Martirosian, G; Szczesny, A | 1 |
Goldsmith, EA; Marino, BJ; Musher, DM; Wanahita, A | 1 |
Glinka, D; Meisel-Mikołajczyk, F; Obuch-Woszczatyński, P; Pituch, H; Łazińska, B; Łuczak, M | 1 |
Chu, C; Greenberg, DP; Hussain, SZ; Khan, S; Orenstein, D | 1 |
Bartoloni, A; Benedetti, M; Dei, R; Goldstein, BP; Mantella, A; Paradisi, F; Sbaragli, S | 1 |
Basu, A; Fung, JJ; Keven, K; Marcos, A; Re, L; Shapiro, R; Simmons, RL; Starzl, TE; Tan, H | 1 |
Adachi, G; Akutagawa, H; Edagawa, G; Egashira, Y; Hirata, I; Katsu, K; Kurisu, Y; Shibayama, Y; Takada, K | 1 |
Anton, PM; Eisenstein, B; Kelly, CP; Kokkotou, E; Michaelis, A; O'Brien, M; Paraschos, S; Pothoulakis, C; Rothstein, D | 1 |
Ravid, M | 1 |
Furui, J; Haraguchi, M; Kanematsu, T; Komuta, K | 1 |
Oldfield, EC | 1 |
Schroeder, MS | 1 |
Surawicz, CM | 1 |
Brazier, J; Burmeister, S; Lewis, S | 1 |
Aslam, S; Bhaila, I; Borchert, F; Hamill, RJ; Logan, N; Musher, DM; Nallacheru, S | 1 |
Gerding, DN | 3 |
Alary, ME; Bourassa, C; Fulop, K; Godin, D; Pepin, J; Raiche, E; Ruel, J; Valiquette, L | 1 |
Alonso, R; Bouza, E; Muñoz, P | 1 |
Hayakawa, T; Hibi, T; Imaeda, H; Ishii, H; Iwao, Y; Komoto, S; Maruta, K; Nakamura, M; Ogata, H; Shiozu, H | 1 |
Aslam, S; Hamill, RJ; Musher, DM | 1 |
Starr, J | 1 |
Baines, SD; Freeman, J; Jabes, D; Wilcox, MH | 1 |
Bac, DJ; Dingemans-Dumas, AM; Visser, WE | 1 |
Arango, JI; Bradshaw, P; Callander, NS; Freytes, CO; Ochoa-Bayona, JL; Patterson, J; Restrepo, A; Restrepo, MI; Schneider, DL | 1 |
Daum, RS; Glikman, D; Kahanna, M; Vora, S | 1 |
Jakobsen, L; Tvede, M | 1 |
Alpert, MA; Aradhyula, S; Bhutto, SS; Hafidh, SA; Manian, FA | 1 |
Cadle, RM; Darouiche, RO; Mansouri, MD | 1 |
Høiby, N; Tvede, M | 1 |
Chasan-Taber, S; Davidson, DM; Dow, G; Garber, G; John, JF; Johnson, D; Louie, TJ; Mohammed, R; Peppe, J; Simon, S; Watt, CK; Weiss, K | 1 |
Delaney, JA; Dial, S; Schneider, V; Suissa, S | 1 |
Cunningham, R | 1 |
Beyer, I; Byl, B; Cherifi, S; Delmee, M; Mascart, G; Van Broeck, J | 1 |
Cicogna, CE; Kuyumjian, AG; Surowiec, D; Wynd, MA | 1 |
Heins, JR | 1 |
Alcides, AP; Avelar, KE; Balassiano, IT; Boente, RF; Brazier, JS; de Paula, GR; Domingues, RM; Ferreira, EO; Ferreira, MC; Miranda, KR; Pinto, LJ | 1 |
Dohi, Y; Kimura, Y; Mizokami, M; Nakamura, N; Orito, E; Sato, K; Tokuda, H | 1 |
Galang, M; Gerding, DN; Johnson, S; Kelly, CP; Schriever, C | 1 |
Hornillos Calvo, M; Pareja Sierra, T | 1 |
Bakkanagari, SR; Davis, MB; Moorthi, KM; Zar, FA | 1 |
Hassoun, A; Ibrahim, F | 1 |
Nelson, R | 1 |
Pakyz, A | 1 |
Koh, TH; Song, KP; Tan, AL; Tan, ML; Wang, G | 1 |
Brazeau, I; Gagnon, S; Pépin, J; Routhier, S; Valiquette, L | 1 |
Shen, EP; Surawicz, CM | 1 |
Mladenova, I; Pekova, L; Pellicano, R; Shomov, G | 1 |
Hooker, M | 1 |
Gerding, DN; Muto, CA; Owens, RC | 1 |
Halsey, J | 1 |
Pepin, J | 1 |
Al-Nassir, WN; Donskey, CJ; Li, Y; Pultz, MJ; Riggs, MM; Sethi, AK | 1 |
Kuipers, EJ; Surawicz, CM | 1 |
Carter, JE; Mizell, KN | 1 |
Kuijper, EJ; Wilcox, MH | 1 |
Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Jump, RL; Nerandzic, MM; Sethi, AK | 1 |
Gugler, R; Steudel, HC | 1 |
Dyson, PH; Schapira, AH | 1 |
Bolton, RP | 1 |
Batts, DH; Fekety, R; Green, EG; Hamilton, JP; Schwartz, JN; Silva, J; Stamper, L | 1 |
Lamont, JT; Trnka, YM | 1 |
Arbogast, JG; Liebig, CW; Ponte, CD | 1 |
Burdon, DW | 2 |
Drapkin, MS | 1 |
McDonald, AJ; Milstone, EB; Scholhamer, CF | 1 |
Buggy, B; Deery, HG; Fekety, R; Silva, J | 1 |
Acikalin, T; Smith, J | 1 |
Lofgren, RP; Soltis, RD; Tadlock, LM | 1 |
Pfitzner, U | 1 |
Baer, M; Grönroos, P; Mäki, M; Vesikari, T | 1 |
Eliopoulos, GM; Spitzer, PG | 1 |
Mehta, JB; Thomas, E | 1 |
Burdon, DW; Hawker, PC; Hine, KR; Keighley, MR; Thompson, H | 1 |
Borriello, SP; Glazer, G; Phillips, RK | 1 |
Brown, JR | 1 |
Brown, R; Wise, R | 1 |
Wu, A | 1 |
Gilligan, PH; Long, SS; Prebis, JW; Thompson, CM | 1 |
Brabyn, DG; Chance, GW; Han, VK; Sayed, H; Shaheed, WA | 1 |
Blake, M; Koornhof, HJ; Miliotis, M; Miller, SD; Still, C; Taubin, A | 1 |
Tedesco, FJ | 5 |
Accardo, P; Bortone, AM; D'Imperio, N; Dal Monte, PR; Formica, G; Giuliani-Piccari, G; Simoni, S | 1 |
Loeschke, K | 1 |
Arabi, Y; Bentley, S; Burdon, DW; Johnson, M; Keighley, MR; Mogg, GA; Youngs, D | 1 |
Herlihy, KJ; Powell, DW; Saco, LS | 1 |
Fahrländer, H | 1 |
Keighley, MR | 2 |
Bartlett, JG; Chang, T; Lowe, B; Shull, S; Tedesco, FJ | 1 |
Cherry, RD; Daly, DS; Goresky, CA; Jabbari, M; Kinnear, DG; Portnoy, D | 1 |
Chevrel, B | 1 |
Eglinton, GS; Mayes, GR; Potts, DW | 1 |
Lamont, JT; Levine, HG | 1 |
Finegold, SM; George, WL; Harding, GK; Klein, R; Putnam, CW; Rolfe, RD | 1 |
Meuwissen, SG; Mulder, CJ; Reiss, M; Rietra, PJ; Van Leeuwen, AM; Visser, J | 1 |
Pennington, CR; Ritchie, PH | 1 |
Beesley, J; Eastham, EJ; Jackson, RH; Nelson, R | 1 |
Rampling, A; Swayne, RL; Warren, RE | 1 |
Fekety, R; Kim, KH; Silva, J; Toshniwal, R | 1 |
Bartlett, JG; Moskovitz, M | 1 |
Bartlett, JG; Viscidi, RP | 1 |
Murray, D; Portnoy, D; Richards, GK; Soneji, A | 1 |
Freeman, HJ; Owen, D; Rabeneck, L | 1 |
Berman, MM; Helgason, H; Hyams, JS | 1 |
Bartlett, JG; Taylor, NS | 1 |
Oliver, PR | 1 |
Bartlett, JG; Chang, TW; Gorbach, SL; Saginur, R | 1 |
Bartlett, JG; Mendelow, H; Wald, A | 1 |
Moore, B; Philpot, CR; Rich, G; Wilkinson, IJ | 1 |
Finegold, SM; George, WL; Rolfe, RD | 1 |
Friedman, RJ; Galambos, JT; Hersh, T; Mayer, IE | 1 |
Bowman, RA; Riley, TV | 1 |
Roberts, RK; Seneviratne, E | 1 |
Rampling, A; Sykes, HV; Warren, RE | 1 |
Barats, JC; Haegy, JM; Laplatte, G | 1 |
Batts, DH; Browne, RA; Cudmore, MA; Fekety, R; Kim, KH; Silva, J; Toshniwal, R; Wilson, KH | 1 |
Bartlett, JG; Chang, T; Dzink, J; Taylor, NS | 1 |
Eriksson, S | 1 |
Malchow-Møller, A; Matzen, P | 1 |
Cox, JN; Eisenhoffer, N; Nusslé, D | 1 |
Miller, JA; Oldenburger, D | 1 |
Levine, M; Ling, EW; McDougal, A | 1 |
Pote, HH; Schenfeld, LA | 1 |
Chan, SM; Chia, JK; Goldstein, H | 1 |
Armstrong, CJ; Wilson, TS | 1 |
Benfiguig, K; Eugène, C; Merrer, J; Mitry, E; Tordjman, R | 1 |
Kubo, M; Satoh, T; Wada, Y | 1 |
Fraser, GM; Inbar-Yanai, I; Niv, Y | 1 |
Gerding, DN; Lee, JT; Olson, MM; Shanholtzer, CJ | 1 |
Barton, TL; Bublin, JG | 1 |
Demling, L; Stoll, R | 1 |
Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC | 1 |
Messick, CR; Reinke, CM | 1 |
Bacon, AE; Caputo, GM; Weitekamp, MR; Whitener, C | 1 |
Dean, PC; Farquhar, DS; Gremse, DA | 1 |
Brandt, LJ; Lu, SS; Schwartz, JM; Simon, DM | 1 |
Hoppen, T; Keller, KM; Rister, M; Stolte, M | 1 |
Carrel, T; Mihaljevic, T; Opravil, M; Pasic, M; Turina, M; von Segesser, L | 1 |
Berman, DS; Wenglin, BD | 1 |
Avicolli, AS; Goldman, WM; Lutwick, S | 1 |
Jacobs, NF | 1 |
Beattie, TJ; Burgner, DP; Rfidah, H; Seal, DV | 1 |
Carrel, T; Jost, R; Pasic, M; Turina, M; Von Segesser, L | 1 |
Clark, KH; Haley, T; Jernigan, TW | 1 |
Cappell, MS; Philogene, C | 1 |
Borucki, MJ; Clench, MH; Cozart, JC; Kalangi, SS; Pollard, RB; Soloway, RD; Taylor, DR | 1 |
Rexroth, G | 1 |
Dever, LL; Eng, RH; Handwerger, S; Smith, SM | 1 |
Johnson, TR; Pitt, HA; Sciscione, AC; Villeneuve, JB | 1 |
Alexander, F; Grundfest-Broniatowski, S; Lavery, I; Milsom, J; Quader, M; Walsh, RM | 1 |
Schweitzer, MA; Silver, DL; Stellato, TA; Sweiss, I | 1 |
Linscheid, RL; O'Duffy, JD; Wright, TW | 1 |
Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
Fujita, K; Kato, H; Kato, N; Sakata, Y; Ueno, K; Watanabe, K | 1 |
Dare, A; Lapiński, TW | 1 |
Golden, WE; Pitts, B; Sanchez, N | 1 |
Davis, JM; Hong, J | 1 |
Kurita, S; Nagatake, T; Ohishi, K; Rikitomi, N; Sato, A; Uchida, R; Watanabe, H | 1 |
Mack, D; Nierhaus, A; Pollok, JM; Pothmann, W; Schäfer, P | 1 |
Brewrink, J; Cross, AS; McCarter, RJ; Morris, JG; Roghmann, MC | 1 |
Kelly, CP; LaMont, JT | 1 |
Hazir, T; Jan, IA; Khan, MA; Khan, NA; Qazi, A | 1 |
Kavan, P; Koutecky, J; Lochmann, O; McClain, LK; Nyc, O; Skala, PJ; Sochor, M | 1 |
Hager, K; Ruwe, A | 1 |
Brooks, S; Friedeman, L; Griffith, J; Hameed, R; Khan, A; Mukherji, R; Schupf, N; Stoica, D | 1 |
Corpuz, M; Nair, S; Pitchumoni, CS; Yadav, D | 1 |
Calişkaner, Z; Koçar, IH; Pay, S; Turan, M | 1 |
Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Rubin, M; Surawicz, CM | 1 |
Hoshika, K | 1 |
Luk, WK; Wong, SS; Woo, PC; Yuen, KY | 1 |
Byrne, P; Fekety, R; Joseph, R; Miller, JM; Silva, J | 1 |
Campbell, I; Shedda, S; Skinner, I | 1 |
Bianchi, L; Furlanut, M; Pea, F | 1 |
McVay, CS; Rolfe, RD | 1 |
Alcantara, CS; Guerrant, RL | 1 |
Borjal, D; Bowen, K; Brandmarker, S; Elmer, GW; Fekety, R; Garcia, RJ; Greenberg, RN; McFarland, LV; Mulligan, ME; Rubin, M; Surawicz, CM | 1 |
Ballmer, PE; Bergamin, B; Hess, T; Imoberdorf, R; Jost, R | 1 |
Jones, RL | 1 |
Calderwood, SB; Mylonakis, E; Ryan, ET | 1 |
Kelly, CP; Kyne, L | 1 |
Kerst, JM; Kuijper, EJ; van der Lelie, J | 1 |
Bouza, E; Muñòz, P; Palomo, J; Yáñèz, J | 1 |
Nieuwenhuis, R; Shetler, K; Triadafilopoulos, G; Wren, SM | 1 |
Chao, L; Nathanson, DR; Sheahan, M; Wallack, MK | 1 |
Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S | 1 |
Apisarnthanarak, A; Crippin, JS; Khoury, H; Mundy, LM; Reinus, WR | 1 |
Kański, A; Martirosian, G; Szczesny, A | 1 |
Alcalá, L; Alonso, R; Bouza, E; García-Lechuz, JM; Peláez, T; Rodríguez-Créixems, M | 1 |
Siristonpun, Y; Tanphaichitra, D | 1 |
Esposito, AL; Gleckman, RA | 1 |
Delchier, JC; Modigliani, R | 1 |
Borriello, SP; Larson, HE; Levi, AJ | 1 |
Bartlett, JG; Christie, D; Gurwith, M; Markham, R; Tedesco, F | 1 |
Burdon, DW; George, RH; Johnson, EM; Youngs, DJ | 1 |
Finch, RG; George, RH; Lewis, MJ; Slack, RC; Thomas, HJ | 1 |
Del Favero, A; Menichetti, F; Morelli, A; Narducci, F; Pelli, MA | 1 |
Bartlett, JG; Chang, TW; Onderdonk, AB | 1 |
Bartlett, JG; Chang, TW; Gamble, W; Napier, J; Tedesco, FJ | 1 |
Cook, FV; Farrar, WE | 1 |
Arabi, Y; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Thompson, H; Williams, JA; Youngs, D | 1 |
Saffouri, B | 1 |
Finegold, SM; George, WL; Liechty, EJ; Mok, HY; Richman, DD; Rolfe, RD; Stiner, DB; Volpicelli, NA | 1 |
Crow, J; Larson, HE; Price, AB | 1 |
Alexander-Williams, J; Arabi, Y; Brown, JD; Burdon, DW; George, RH; Keighley, MR; Shinagawa, N; Youngs, DJ | 1 |
Werner, H | 1 |
Alexander-Williams, J; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Youngs, D | 1 |
Esaki, PE; Saadah, HA | 1 |
Kerrihard, GN | 1 |
Broitman, SA; Katz, L; LaMont, JT; Rieth, S; Rothman, SW; Sonnenblick, EB; Trier, JS | 1 |
Long, CI; Vannatta, JB | 1 |
Badley, BW; Comeau, SA; Faulkner, RS; Hartlen, MR; Marrie, TJ; Miller, HR | 1 |
Brun-Buisson, C; Chapman, A; Himmich, H; Voinchet, O | 1 |
Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J | 1 |
Bartlett, JG; Cisneros, RL; Onderdonk, AB | 1 |
Abrams, GD; Boyd, DI; Browne, RA; Fekety, R; Silva, J; Work, CO | 1 |
Ledger, WJ; Puttler, OL | 1 |
Bettin, KM; Clabots, CR; Gerding, DN; Homann, SR; Johnson, S; Peterson, LR; Quick, JN | 1 |
Spencer, RC; Wilcox, MH | 1 |
Bagwell, CE; Langham, MR; Mahaffey, SM; Shandling, B; Talbert, JL | 1 |
McGurrey, E | 1 |
Barkin, JS; Gregg, PA; Kershenobich, D; Lubin, J; Wiesen, S | 1 |
de Lalla, F; Manfrin, V; Nicolin, R; Rigoli, R; Rinaldi, E; Scarpellini, P; Tramarin, A | 1 |
Langdale, V; Levene, M; MacKay, P; Martin, C; Millar, MR | 1 |
Chen, C | 1 |
Arning, M; Aul, C; Chlebowski, H; Gehrt, A; Hadding, U; Schneider, W; Wolf, M | 1 |
Dru, M | 1 |
Dielman, DG; McCullough, JM; Peery, D | 1 |
Changchien, CS; Chen, PC; Chiu, CT; Chuah, SK; Lin, HH; Wu, CS | 1 |
Ariano, RE; Harding, GK; Zhanel, GG | 1 |
Ebina, K; Hirano, T; Ohi, H; Sugawara, A | 1 |
Aprahamian, C; Bergstein, JM; Kramer, A; Quebbeman, EJ; Wittman, DH | 1 |
Montes de Oca, G; Oh, T; Osorno, RJ | 1 |
Wheeler, WE; Yarinsky, S | 1 |
Cerf, M; Levecq, H | 1 |
Barile, C; Conforti, M; Merlo, M; Violato, F | 1 |
Guglielmo, BJ; Jacobs, R; Oliva, SL; Pons, VG | 1 |
Chamovitz, BN; McKenna, JP | 1 |
Chinn, J; Elmer, G; McFarland, LV; Surawicz, CM | 1 |
Silva, J | 1 |
Ritchie, M | 1 |
Chang, TW; Dong, MY; Gorbach, SL | 1 |
Lindmark, A; Nord, CE; Persson, I | 1 |
Gupta, R; Sachar, DB | 1 |
Hecht, JR; Olinger, EJ | 1 |
Cardines, R; Gianfrilli, P; Luzzi, I; Pantosti, A | 1 |
Chen, DC; Chen, MJ; Chen, YF; Ma, S; Tang, WS; Xie, XL | 1 |
Filston, HC; Friedman, HS; Gutman, LT; Rourk, MH; Shorter, NA; Ware, R | 1 |
Dear, PR; Ng, PC; Thomas, DF | 1 |
Hausmann, L; Tacke, W | 1 |
Avesani, V; Delmée, M; Michaux, JL; Vandercam, B | 1 |
Bingley, PJ; Harding, GM | 1 |
Roda, PI | 1 |
Cattau, EL; Van Ness, MM | 1 |
Bick, RJ; Haaga, JR; Zollinger, RM | 1 |
Miller, SN; Ringler, RP | 1 |
Elmer, GW; McFarland, LV | 1 |
Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A | 1 |
Goh, KL; Peh, SC; Wong, NW | 1 |
Fussell, S; Ginter, GL; Olsen, E; Pendray, M; Scheifele, DW | 1 |
Dolan, PJ; Goodpasture, HC; Jacobs, ER; Meredith, WT | 1 |
Beart, RW; Talbot, RW; Walker, RC | 1 |
Brownlee, K; Dear, P; Tulloh, R | 1 |
Bogokowsky, B; Chagnac, A; Lurie, B | 1 |
Church, JM; Fazio, VW | 1 |
Arsura, EL; Fazio, RA; Wickremesinghe, PC | 1 |
Amin, NM | 1 |
Balmaseda, MT; Johnson, DK | 1 |
Adams, GL; Griebie, M | 1 |
Bayley, N; Gordon, D; Hecker, R; Higgins, G; Labrooy, J; McDonald, MI; Trapani, JA; Ward, PB; Young, GP | 1 |
Barzilai, A; Eitan, A; Erlich, N; Toledano, C | 1 |
Fortson, WC; Gordon, D; Tedesco, FJ | 1 |
Anderson, GD; McNeeley, SG; Sibai, BM | 1 |
Henderson, IS; Leung, AC; McLay, A; Orange, G | 1 |
Li, ZJ; Liu, LX; Niu, HZ; Song, HY; Zhang, XY | 1 |
Riley, HD | 1 |
Hall, WH; Khan, MY | 2 |
103 review(s) available for vancomycin and Antibiotic-Associated Colitis
Article | Year |
---|---|
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vancomycin | 2022 |
Evolving Strategies to Manage Clostridium difficile Colitis.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Bacterial Toxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Ileostomy; Risk Factors; Therapeutic Irrigation; Vancomycin | 2020 |
Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Humans; Randomized Controlled Trials as Topic; Vancomycin | 2017 |
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Metronidazole; Probiotics; Vancomycin | 2018 |
Prevention and Treatment of Clostridium difficile Enterocolitis.
Topics: Clostridioides difficile; Colectomy; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Incidence; Male; Metronidazole; Risk Assessment; Severity of Illness Index; United States; Vancomycin | 2018 |
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antimicrobial Stewardship; Broadly Neutralizing Antibodies; Clostridium Infections; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Hand Hygiene; Health Care Costs; Humans; Infection Control; Kidney Failure, Chronic; Length of Stay; Metronidazole; Patient Isolation; Renal Insufficiency, Chronic; Secondary Prevention; Vancomycin | 2019 |
[Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2013 |
[Clostridium difficile infection: epidemiology, disease burden and therapy].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin | 2013 |
[Clostridium difficile infection: epidemiology, risk factors, pathogenesis, clinical features, diagnosis and therapy].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Metronidazole; Risk Factors; Vancomycin; Virulence | 2013 |
A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.
Topics: Carrier State; Clostridioides difficile; Diabetes Mellitus; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Heart Failure; Humans; Immunosuppression Therapy; Intensive Care Units; Lung Diseases; Methicillin-Resistant Staphylococcus aureus; Nursing Homes; Patient Admission; Renal Insufficiency; Risk Factors; Staphylococcal Infections; Vancomycin | 2013 |
[Fecal transfusion as treatment of Clostridium difficile infection].
Topics: Anti-Infective Agents; Enterocolitis, Pseudomembranous; Feces; Finland; Humans; Intubation, Gastrointestinal; Metronidazole; Therapeutic Irrigation; Vancomycin | 2013 |
Treating Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Probiotics; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2014 |
Methicillin-resistant Staphylococcus aureus enterocolitis sequentially complicated with septic arthritis: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheters; Clone Cells; Community-Acquired Infections; Cross Infection; Diabetes Mellitus, Type 2; Diagnosis, Differential; Disease Susceptibility; Enterocolitis; Enterocolitis, Pseudomembranous; Equipment Contamination; Evolution, Molecular; Feces; Hip Joint; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Pneumococcal; Shock, Septic; Staphylococcal Infections; Synovial Fluid; Vancomycin | 2014 |
Managing Clostridium difficile in inflammatory bowel disease (IBD).
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammatory Bowel Diseases; Opportunistic Infections; Tissue Transplantation; Vancomycin | 2014 |
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2014 |
Treatment of recurrent and severe Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Metronidazole; Microbiota; Recurrence; Severity of Illness Index; Transplantation; Vancomycin | 2015 |
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Incidence; Metronidazole; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Probiotics; Recurrence; Risk Factors; Vancomycin | 2015 |
Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
[Oncologic aspects of Clostridium difficile].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin | 2016 |
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Randomized Controlled Trials as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2017 |
Maculopapular rash induced by oral vancomycin.
Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Exanthema; Female; Humans; Vancomycin | 2008 |
Clostridium difficile: a reemerging pathogen.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Communicable Diseases, Emerging; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2008 |
Clostridium difficile infection in solid organ transplant recipients.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Digestive System Surgical Procedures; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Organ Transplantation; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin; Virulence | 2008 |
[Clostridium-difficile-associated diarrhea].
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin | 2009 |
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: causality and therapeutic approaches.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunotherapy; Metronidazole; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
Clostridium difficile infection in the intensive care unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Incidence; Intensive Care Units; Metronidazole; Vancomycin | 2009 |
[Infections with Clostridium difficile following antibiotic therapy].
Topics: Administration, Oral; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Endoscopy; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Recurrence; Time Factors; Vancomycin | 2009 |
Clostridium difficile enteritis after colectomy.
Topics: Adult; Anti-Bacterial Agents; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Vancomycin | 2009 |
[Clostridium-difficile-associated infections].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Clostridioides difficile; Combined Modality Therapy; Disease Outbreaks; Enterocolitis, Pseudomembranous; Enterotoxins; Europe; Fluid Therapy; Humans; Incidence; Metronidazole; Molecular Sequence Data; North America; Ribotyping; Vancomycin; Virulence | 2010 |
Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clinical Trials as Topic; Clostridioides difficile; Cross Infection; DNA-Directed RNA Polymerases; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Equipment Contamination; Humans; Infection Control; Long-Term Care; Metronidazole; Risk Factors; Severity of Illness Index; Vancomycin | 2010 |
Clostridium difficile bacteremia, Taiwan.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Taiwan; Vancomycin; Young Adult | 2010 |
Clostridium difficile: an update for the primary care clinician.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin | 2010 |
Post-esophagectomy pseudomembranous inflammation of the interposed colon.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Colon; Enterocolitis, Pseudomembranous; Esophagectomy; Humans; Male; Middle Aged; Postoperative Complications; Vancomycin | 2010 |
Management of Clostridium difficile infection: thinking inside and outside the box.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vaccination; Vancomycin | 2010 |
Clostridium difficile infection: epidemiology, risk factors and management.
Topics: Clostridioides difficile; Colitis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prevalence; Risk Factors; Vancomycin | 2011 |
Clostridium difficile: progress and challenges.
Topics: Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Polymerase Chain Reaction; Practice Guidelines as Topic; Vancomycin | 2010 |
Treatment of refractory and recurrent Clostridium difficile infection.
Topics: Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin | 2011 |
Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hospitalists; Humans; Incidence; Internal Medicine; Metronidazole; Severity of Illness Index; Vancomycin | 2011 |
Clostridium difficile infection in older adults: a review and update on its management.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2012 |
Meeting the challenge of recurrent Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Hygiene; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Vancomycin | 2012 |
Current strategies for management of initial Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin | 2012 |
Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?
Topics: Bacterial Infections; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Necrotizing; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Pneumonia, Ventilator-Associated; Probiotics; Vancomycin | 2012 |
Novel management strategies in the treatment of severe Clostridium difficile infection.
Topics: Algorithms; Anti-Infective Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Immunization; Metronidazole; Prognosis; Recurrence; Risk Factors; Vancomycin | 2012 |
[Treatment of refractory or recurrent Clostridium difficile infection].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Probiotics; Recurrence; Vancomycin | 2012 |
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides difficile; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2013 |
Epidemiology, diagnosis and treatment of Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin | 2012 |
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colitis; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Radiography; Risk Factors; Treatment Outcome; Vancomycin | 2002 |
[Pseudo-membranous colitis].
Topics: Bacterial Proteins; Bacterial Toxins; Biomarkers; Clostridioides difficile; Cross Infection; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Vancomycin | 2003 |
[Treatment of infections associated with Clostridium difficile].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin | 2003 |
[4 cases of pseudomembranous colitis due to antituberculous agents].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus acidophilus; Male; Treatment Outcome; Vancomycin | 2004 |
Clostridium difficile--associated diarrhea.
Topics: Aged; Algorithms; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Metronidazole; Vancomycin | 2005 |
Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Lactobacillus; Metronidazole; Probiotics; Vancomycin | 2005 |
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin | 2005 |
Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Probiotics; Secondary Prevention; Vaccination; Vancomycin; Vancomycin Resistance | 2005 |
Clostridium difficile associated diarrhoea: diagnosis and treatment.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2005 |
Past, present, and future therapies for Clostridium difficile-associated disease.
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Forecasting; Humans; Metronidazole; Probiotics; Recurrence; Vancomycin | 2006 |
Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Recurrence; Risk Factors; Saccharomyces; Vancomycin | 2006 |
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Beclomethasone; Biopsy; Budesonide; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infection Control; Male; Metronidazole; Middle Aged; Oncology Nursing; Primary Myelofibrosis; Risk Factors; Tacrolimus; Vancomycin | 2007 |
Treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Disease Management; Enterocolitis, Pseudomembranous; Humans; Metronidazole; North America; Recurrence; Therapies, Investigational; Vancomycin | 2008 |
Current and future treatment modalities for Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2008 |
The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; History, 20th Century; History, 21st Century; Humans; Metronidazole; Vancomycin | 2008 |
Clostridium difficile colitis.
Topics: Adult; Animals; Anti-Bacterial Agents; Carrier State; Child; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Cricetinae; Crohn Disease; Cross Infection; Cytotoxins; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Infant; Infant, Newborn; Vancomycin | 1984 |
Pseudomembranous colitis: a case report and literature review.
Topics: Aged; Bacitracin; Enterocolitis, Pseudomembranous; Erythromycin; Female; Humans; Metronidazole; Vancomycin | 1984 |
Antibiotic-associated colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin | 1984 |
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1984 |
[Antibiotic-associated diarrhoea and enterocolitis (author's transl)].
Topics: Adult; Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
Pseudomembranous (antibiotic-associated) colitis.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Colestipol; Colon; Enterocolitis, Pseudomembranous; Humans; Prognosis; Vancomycin | 1981 |
[Pseudomembranous colitis. Aetiology, clinic and treatment (author's transl)].
Topics: Cholestyramine Resin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Humans; Ischemia; Lincomycin; Metals; Staphylococcal Infections; Tetracycline; Vancomycin | 1982 |
Pseudomembranous colitis.
Topics: Anion Exchange Resins; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Intestinal Mucosa; Leukocytes; Lincomycin; Metronidazole; Vancomycin | 1982 |
Pseudomembranous colitis: pathogenesis and therapy.
Topics: Anti-Bacterial Agents; Atropine; Bacitracin; Botulinum Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colestipol; Diphenoxylate; Drug Combinations; Enterocolitis, Pseudomembranous; Gastrointestinal Agents; Humans; Intestinal Mucosa; Metronidazole; Vancomycin | 1982 |
Diarrhea associated with parenteral vancomycin therapy.
Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Kidney Failure, Chronic; Male; Middle Aged; Staphylococcal Infections; Vancomycin | 1995 |
Rectal use of vancomycin.
Topics: Administration, Oral; Administration, Rectal; Clostridioides difficile; Enema; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin | 1994 |
Update on Clostridium difficile-induced colitis, Part 2.
Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Drug Costs; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1994 |
Clostridium difficile infection: a common clinical problem for the general internist.
Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Family Practice; Humans; Metronidazole; Vancomycin | 1994 |
Antibiotic-induced diarrhea and pseudomembranous colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Cytotoxins; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Incidence; Infection Control; Metronidazole; Primary Prevention; Sensitivity and Specificity; Sigmoidoscopy; Vancomycin | 1994 |
Surgery for pancreatic tumors during pregnancy: a case report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Cerebral Hemorrhage; Cesarean Section; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fetal Distress; Fluid Therapy; Humans; Infant, Newborn; Pancreatic Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Risk Factors; Vancomycin | 1996 |
Clostridium difficile colitis in the critically ill.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Colectomy; Combined Modality Therapy; Critical Illness; Enterocolitis, Pseudomembranous; Female; Hospital Mortality; Humans; Male; Metronidazole; Middle Aged; Morbidity; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
Nosocomial infections and nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Pneumonia, Bacterial; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 1996 |
Clostridium difficile infection.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin | 1998 |
Clostridium difficile infection in patients with reactive arthritis of undetermined etiology.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Reactive; Bacterial Toxins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Feces; Female; Humans; Male; Prognosis; Prohibitins; Treatment Outcome; Vancomycin | 1998 |
[Pseudomembranous colitis (Clostridium difficile infection)].
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Clostridioides difficile; Diagnosis, Differential; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prognosis; Vancomycin | 1999 |
Update on Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2000 |
Treatment of Clostridium difficile-associated diarrhea and colitis.
Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2000 |
Clostridial enterocolitis.
Topics: Animals; Bacitracin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Disease Outbreaks; Enterocolitis, Pseudomembranous; Horse Diseases; Horses; Metronidazole; Vancomycin | 2000 |
Clostridium difficile--Associated diarrhea: A review.
Topics: Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Practice Guidelines as Topic; Radiography; Vancomycin | 2001 |
Recurrent Clostridium difficile diarrhoea.
Topics: Anion Exchange Resins; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2001 |
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clostridioides difficile; Dexamethasone; Diarrhea; Doxorubicin; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Multiple Myeloma; Treatment Outcome; Vancomycin; Vincristine | 2001 |
New indications for old antibiotics: tetracycline, erythromycin, carbenicillin, and vancomycin revisited.
Topics: Anti-Bacterial Agents; Carbenicillin; Clindamycin; Diarrhea; Enterocolitis, Pseudomembranous; Erythromycin; Humans; Legionnaires' Disease; Lung Diseases; Male; Methicillin; Penicillin Resistance; Prostatitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Tetracycline; Urethritis; Vancomycin | 1979 |
[Antibiotics and pseudomembranous colitis].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Parenteral Nutrition, Total; Vancomycin; Water-Electrolyte Balance | 1979 |
Vancomycin revisited.
Topics: Bacteria; Bacterial Infections; Central Nervous System Diseases; Diphtheria; Drug Hypersensitivity; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Humans; Penicillins; Renal Dialysis; Staphylococcal Infections; Vancomycin | 1978 |
Antibiotic-associated colitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1979 |
Clostridium difficile infection: responses, relapses and re-infections.
Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin | 1992 |
[Current status of Clostridium difficile: recent advances in diagnostic materials and treatment of colitis and diarrheas associated with antibiotic therapy].
Topics: Causality; Clinical Protocols; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Recurrence; Vancomycin | 1991 |
Oral vancomycin-induced rash: case report and review of the literature.
Topics: Administration, Oral; Aged; Aged, 80 and over; Drug Eruptions; Enterocolitis, Pseudomembranous; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Pruritus; Vancomycin | 1991 |
[Pseudomembranous colitis: a clinical analysis and review of literatures].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1991 |
Update on pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Humans; Metronidazole; Patient Isolation; United States; Vancomycin | 1989 |
[Pseudomembraneous colitis following antibiotic administration--a diagnostic and therapeutic challenge].
Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Middle Aged; Ofloxacin; Oxazines; Vancomycin | 1988 |
Fulminant colitis complicating antibiotic-associated pseudomembranous colitis: case report and review of the clinical manifestations and treatment.
Topics: Clindamycin; Colectomy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Male; Middle Aged; Proctoscopy; Vancomycin | 1987 |
Vancomycin and novobiocin.
Topics: Deafness; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Fever; Humans; Novobiocin; Sepsis; Staphylococcal Infections; Vancomycin | 1970 |
37 trial(s) available for vancomycin and Antibiotic-Associated Colitis
Article | Year |
---|---|
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Middle Aged; Vancomycin | 2018 |
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonoscopy; Combined Modality Therapy; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Vancomycin | 2018 |
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Secondary Prevention; Treatment Outcome; Vancomycin | 2013 |
[Challenges of Clostridium difficile infection].
Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin | 2013 |
Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitalization; Humans; Kidney Transplantation; Length of Stay; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Vancomycin; Wisconsin | 2014 |
[Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces].
Topics: Adult; Combined Modality Therapy; Drug Resistance, Microbial; Early Termination of Clinical Trials; Enema; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Isotonic Solutions; Male; Metronidazole; Retreatment; Secondary Prevention; Vancomycin | 2014 |
Fecal microbiota transplant after hematopoietic SCT: report of a successful case.
Topics: Allografts; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Microbiota; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 2015 |
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Microbiota; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Connecticut; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Male; Middle Aged; Polymerase Chain Reaction; Vancomycin | 2016 |
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Humans; Male; Microbiota; Middle Aged; Ontario; Recurrence; Vancomycin; Young Adult | 2017 |
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Nitro Compounds; Prospective Studies; Thiazoles; Treatment Outcome; United States; Vancomycin | 2009 |
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
Topics: Aged; Aged, 80 and over; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Environmental Microbiology; Feces; Female; Hospital Units; Humans; Male; Metronidazole; Middle Aged; Ribotyping; Skin; Spores, Bacterial; Treatment Outcome; Vancomycin | 2010 |
Treatment with monoclonal antibodies against Clostridium difficile toxins.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Antitoxins; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Secondary Prevention; Vancomycin; Young Adult | 2010 |
Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Immunoassay; Intestinal Absorption; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Vancomycin | 2011 |
Fidaxomicin versus vancomycin for Clostridium difficile infection.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Intention to Treat Analysis; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Secondary Prevention; Treatment Outcome; Vancomycin | 2011 |
Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Prohibitins; Vancomycin | 2011 |
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Vancomycin | 2012 |
Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
Topics: Adolescent; Adult; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Spores, Bacterial; Vancomycin; Young Adult | 2012 |
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Remission Induction; Risk Factors; Vancomycin | 2002 |
Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antidiarrheals; Bifidobacterium; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Oligosaccharides; Probiotics; Secondary Prevention; Treatment Outcome; Vancomycin | 2005 |
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Ions; Male; Middle Aged; Polymers; Polystyrenes; Sulfonic Acids; Vancomycin | 2006 |
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Therapeutic trials of antibiotic associated colitis.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colestipol; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Humans; Polyamines; Vancomycin | 1980 |
Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: a prospective controlled study.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; HIV Seropositivity; Humans; Male; Metronidazole; Prospective Studies; Vancomycin | 1994 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Health Care Costs; Hospitalization; Humans; Incidence; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 1999 |
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Probiotics; Recurrence; Saccharomyces; Vancomycin | 2000 |
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.
Topics: Bacterial Toxins; Clinical Trials as Topic; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Postoperative Complications; Random Allocation; Vancomycin | 1978 |
Pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1979 |
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
Topics: Aged; Bacterial Typing Techniques; Carrier State; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA Restriction Enzymes; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Prohibitins; Vancomycin | 1992 |
Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Prospective Studies; Teicoplanin; Vancomycin | 1992 |
Enterobacteriaceae and neonatal necrotising enterocolitis.
Topics: Aztreonam; Drug Therapy, Combination; England; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Gentamicins; Humans; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intestine, Large; Vancomycin | 1992 |
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.
Topics: Adult; Anion Exchange Resins; Child; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Ion Exchange Resins; Metronidazole; Vancomycin | 1990 |
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Topics: Antidiarrheals; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin; Yeast, Dried | 1989 |
Treatment of Clostridium difficile colitis.
Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin | 1985 |
Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin.
Topics: Adult; Aged; Bacitracin; Bacterial Toxins; Clostridium; Double-Blind Method; Drug Evaluation; Enterocolitis, Pseudomembranous; Feces; Humans; Middle Aged; Random Allocation; Vancomycin | 1985 |
397 other study(ies) available for vancomycin and Antibiotic-Associated Colitis
Article | Year |
---|---|
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Topics: Animals; Anti-Infective Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Mesocricetus; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Weight Gain | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Effects of inoculum, pH, and cations on the in vitro activity of fidaxomicin (OPT-80, PAR-101) against Clostridium difficile.
Topics: Agar; Aminoglycosides; Anti-Bacterial Agents; Cations; Clostridioides difficile; Colony Count, Microbial; Culture Media; Enterocolitis, Pseudomembranous; Fidaxomicin; Glycosides; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests | 2010 |
Discovery of LFF571: an investigational agent for Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Crystallography, X-Ray; Enterococcus; Enterocolitis, Pseudomembranous; Escherichia coli Proteins; Female; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptide Elongation Factor Tu; Rats; Rats, Sprague-Dawley; Solubility; Staphylococcus aureus; Streptococcus pyogenes; Structure-Activity Relationship; Thiazoles; Water | 2012 |
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship | 2015 |
Seeing C diff differently.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Consumer Health Information; Cost of Illness; Enterocolitis, Pseudomembranous; False Negative Reactions; Humans; Metronidazole; Vancomycin | 2022 |
Commentary: faecal microbiota transplantation-from home brew to holy grail.
Topics: Clostridium Infections; Colonoscopy; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Vancomycin | 2020 |
Successful Treatment of Pseudomembranous Colitis with Fecal Microbiota Transplantation - A Case Study on A Patient Rescued by Extracorporeal Cardiopulmonary Resuscitation After Cardiac Arrest.
Topics: Adolescent; Anti-Bacterial Agents; Cardiopulmonary Resuscitation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Heart Arrest; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2020 |
Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Disease Models, Animal; Drug Repositioning; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Ronidazole; Vancomycin; Veterinary Drugs | 2020 |
Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19.
Topics: Aged; Anti-Bacterial Agents; Cecal Diseases; Cecum; Clostridioides difficile; COVID-19; Enterocolitis, Pseudomembranous; Humans; Intestinal Perforation; Male; SARS-CoV-2; Vancomycin | 2021 |
Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Standard of Care; Treatment Outcome; Vancomycin | 2021 |
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Minocycline; Polymerase Chain Reaction; Retrognathia; Tigecycline; Vancomycin | 2018 |
An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
Topics: Acute Kidney Injury; Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Biological Availability; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Intestine, Large; Male; Middle Aged; Rectal Neoplasms; Renal Replacement Therapy; Respiration, Artificial; Sepsis; Vancomycin | 2017 |
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Microbiome; Intestines; Mice; Mice, Inbred C57BL; Steroids; Vancomycin | 2018 |
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin | 2018 |
Repeated Clostridium difficile infection after living donor liver transplantation.
Topics: Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Immunosuppressive Agents; Length of Stay; Liver Transplantation; Living Donors; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Vancomycin | 2018 |
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Glycogen Storage Disease Type II; Humans; Immunocompetence; Infant; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin | 2018 |
Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.
Topics: Anti-Bacterial Agents; Benzoates; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests; Stilbenes; Vancomycin | 2018 |
Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; China; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Support Techniques; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Gene Frequency; Humans; Male; Middle Aged; Ribotyping; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin | 2018 |
A Case of Recurring Diarrhea in a Young Woman.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Recurrence; Vancomycin | 2019 |
A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitals, Teaching; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Vancomycin; Young Adult | 2018 |
Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities: A case report.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Comorbidity; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Proton Pump Inhibitors; Vancomycin | 2019 |
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Coronary Artery Bypass; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; United States; Vancomycin | 2013 |
Intracolonic vancomycin for severe Clostridium difficile colitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enema; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
Topics: Anti-Bacterial Agents; Bacteriocins; Clostridioides difficile; Depsipeptides; Drug Synergism; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 2013 |
Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Clostridioides difficile; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prednisone; Radiography; Rituximab; Typhlitis; Vancomycin; Vincristine | 2013 |
[Clostridium difficile infections - still a major challenge].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Combined Modality Therapy; Cross Infection; Disease Notification; Enterocolitis, Pseudomembranous; Fidaxomicin; Metronidazole; Probiotics; Vancomycin; Virulence | 2013 |
Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult | 2013 |
A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Endpoint Determination; Enterocolitis, Pseudomembranous; Female; Hematologic Neoplasms; Humans; Incidence; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.
Topics: Adult; Aged; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2013 |
Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefepime; Cefuroxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Factors; Toll-Like Receptor 4; Vancomycin | 2013 |
Medical research. The promise of poop.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Diseases; Humans; Metagenome; Randomized Controlled Trials as Topic; Transplantation; Vancomycin | 2013 |
Fecal transplantation therapy for Clostridium difficile-associated pouchitis.
Topics: Adult; Aminoglycosides; Child; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Male; Pouchitis; Rifamycins; Rifaximin; Vancomycin | 2014 |
[Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
Topics: Aminoglycosides; Clostridioides difficile; Colectomy; Colostomy; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Germany; Humans; Incidence; Metronidazole; Recurrence; Transplantation; Vancomycin | 2014 |
Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon.
Topics: Administration, Topical; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Decompression, Surgical; Enema; Enterocolitis, Pseudomembranous; Humans; Intubation, Gastrointestinal; Megacolon; Vancomycin | 2014 |
Reply to M.R. Green et al.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 2013 |
Is fidaxomicin the drug of choice for treating Clostridium difficile-associated diarrhea in patients with cancer?
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 2013 |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin | 2013 |
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin | 2014 |
[Clostridium difficile infection due to ribotype 027: description of an imported case in Spain].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clostridioides difficile; Disease Susceptibility; DNA, Bacterial; DNA, Ribosomal; Enterocolitis, Pseudomembranous; Female; Humans; Intubation, Intratracheal; Pneumonia, Bacterial; Portugal; Ribotyping; RNA, Bacterial; Sequence Deletion; Spain; Vancomycin; Young Adult | 2014 |
Nonresectional surgical approach to toxic megacolon with abdominal compartment syndrome.
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intra-Abdominal Hypertension; Male; Megacolon, Toxic; Middle Aged; Vancomycin | 2013 |
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2014 |
Intestinal microbiota transplantation: a case of Crohn's colitis with superimposed Clostridium difficile infection.
Topics: Addison Disease; Adult; Anti-Infective Agents; Clostridioides difficile; Crohn Disease; Enterocolitis, Pseudomembranous; Fatal Outcome; Feces; Female; Humans; Intestines; Metagenome; Metronidazole; Microbiota; Superinfection; Vancomycin | 2013 |
A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; High-Throughput Screening Assays; Iron; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium bovis; Phenanthrolines; Small Molecule Libraries; Species Specificity; Vancomycin | 2014 |
Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Toxins; Clostridioides difficile; Edema; Enterocolitis, Pseudomembranous; Enterotoxins; Epithelial Cells; Fibroblasts; Fidaxomicin; Gene Expression; Ileum; Injections, Intralesional; Interleukin-1beta; Intestinal Mucosa; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; RNA, Messenger; Vancomycin | 2014 |
Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Treatment Outcome; Vancomycin | 2014 |
Antibiotic overuse and Clostridium difficile: a teachable moment.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fasciitis, Necrotizing; Fatal Outcome; Female; Humans; Imipenem; Inappropriate Prescribing; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
An agent-based simulation model for Clostridium difficile infection control.
Topics: Anti-Bacterial Agents; Biometry; Clostridioides difficile; Computer Simulation; Cross Infection; Enterocolitis, Pseudomembranous; Hospitals; Humans; Infection Control; Markov Chains; Risk Assessment; Vancomycin; Wisconsin | 2015 |
[Systemic absorption of oral vancomycin in colitis patients. A propos of 2 cases].
Topics: Absorption, Physiological; Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin | 2014 |
Appendicostomy for intraluminal antibiotic administration and extracorporeal membrane oxygenation support in severe Hirschsprung's enterocolitis.
Topics: Anal Canal; Anastomosis, Surgical; Anti-Bacterial Agents; Appendix; Clostridioides difficile; Colon, Sigmoid; Colostomy; Enterocolitis, Pseudomembranous; Extracorporeal Membrane Oxygenation; Feces; Hirschsprung Disease; Humans; Infant, Newborn; Male; Therapeutic Irrigation; Vancomycin | 2014 |
Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germ-Free Life; Humans; Interleukin-8; Microbiota; Minocycline; Pyrimidinones; Swine; Tigecycline; Vancomycin | 2014 |
[Clostridium difficile in visceral surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Germany; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Metronidazole; Middle Aged; Minocycline; Patient Readmission; Retrospective Studies; Survival Rate; Tigecycline; Vancomycin; Young Adult | 2015 |
Emphysematous cystitis due to recurrent Clostridium difficile infection.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin | 2014 |
Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Male; Mice; Mice, Inbred C57BL; Minocycline; Tigecycline; Vancomycin | 2015 |
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin | 2015 |
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Health Care Costs; Humans; Quality-Adjusted Life Years; Vancomycin | 2015 |
The first Clostridium difficile ribotype 027 strain isolated in Taiwan.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Esophageal Neoplasms; Humans; Male; Metronidazole; Shock, Septic; Taiwan; Vancomycin | 2016 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss | 2015 |
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin | 2015 |
Treatment of Clostridium difficile infection in a French university hospital.
Topics: Adult; Aged; Clostridioides difficile; Cohort Studies; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; France; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance.
Topics: Administrative Claims, Healthcare; Aged; Algorithms; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; Clostridioides difficile; Drug Prescriptions; Enterocolitis, Pseudomembranous; Feces; Female; Humans; International Classification of Diseases; Male; Middle Aged; Population Surveillance; Predictive Value of Tests; Recurrence; ROC Curve; Vancomycin | 2015 |
Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Vancomycin | 2015 |
Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2015 |
The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Critical Illness; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2015 |
Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Asian People; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Treatment Outcome; Vancomycin | 2015 |
[Treatment of a severe Clostridium difficile infection with colonic lavages. Report of one case].
Topics: Aged; Animals; Clostridioides difficile; Combined Modality Therapy; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Therapeutic Irrigation; Vancomycin | 2015 |
Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
Topics: Anti-Bacterial Agents; Brain Diseases; Clostridioides difficile; Drug Eruptions; Enterocolitis, Pseudomembranous; Fatal Outcome; Female; Humans; Linear IgA Bullous Dermatosis; Middle Aged; Mouth Diseases; Vancomycin | 2015 |
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin | 2015 |
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment | 2015 |
Using a Novel Lysin To Help Control Clostridium difficile Infections.
Topics: Amidohydrolases; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Catalytic Domain; Clostridioides difficile; Colon; Drug Resistance, Multiple, Bacterial; Endopeptidases; Enterocolitis, Pseudomembranous; Female; Hydrogen-Ion Concentration; Mice, Inbred C57BL; Molecular Sequence Data; Prophages; Recombinant Proteins; Vancomycin; Viral Proteins | 2015 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
[A Serious Case of Pseudomembranous Colitis in which Treatment with Endoscopic Vancomycin Sprinkling Got a Good Result].
Topics: Aged; Colonoscopy; Enterocolitis, Pseudomembranous; Humans; Male; Treatment Outcome; Vancomycin | 2015 |
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
Topics: Anti-Bacterial Agents; Canada; Clostridioides difficile; Cohort Studies; Cost of Illness; Enterocolitis, Pseudomembranous; Hospitalization; Incidence; Metronidazole; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2016 |
The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2016 |
Reply to Young, Ochi, and Marimuthu.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Vancomycin | 2016 |
Hypo-Hypo: A Complex Metabolic Disorder.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fludrocortisone; Humans; Hyperkalemia; Hypoaldosteronism; Kidney; Male; Mineralocorticoids; Treatment Outcome; Vancomycin | 2016 |
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
Topics: Anti-Bacterial Agents; Bacterial Load; Bacteroides fragilis; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Tract; Humans; Microbiota; Models, Biological; Recurrence; Vancomycin | 2016 |
Clostridium difficile ileitis in a patient, after total colectomy.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Colectomy; Colonic Neoplasms; Enterocolitis, Pseudomembranous; Humans; Ileitis; Male; Middle Aged; Polymerase Chain Reaction; Tomography, X-Ray Computed; Vancomycin | 2016 |
Misanalysis of Urinalysis: A Teachable Moment.
Topics: Analgesics, Opioid; Anti-Bacterial Agents; Cefpodoxime; Ceftizoxime; Clonidine; Diagnostic Errors; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Low Back Pain; Middle Aged; Muscle Relaxants, Central; Pyuria; Substance Withdrawal Syndrome; Tramadol; Urinalysis; Urinary Tract Infections; Vancomycin | 2016 |
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Topics: Anti-Bacterial Agents; Australia; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Health Care Costs; Humans; Intestines; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Clostridium difficile Associated Diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin | 2016 |
Pseudomembranous colitis secondary to methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Administration, Oral; Adult; Enterocolitis, Pseudomembranous; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
[Antibiotic treatment of clostridial colitis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colon; Drug Administration Routes; Enterocolitis, Pseudomembranous; Female; Humans; Intensive Care Units; Male; Megacolon, Toxic; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2016 |
Pseudomembranous colitis presenting as a mechanical large bowel obstruction.
Topics: Administration, Intravenous; Administration, Oral; Anastomosis, Surgical; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Diatrizoate Meglumine; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intestinal Obstruction; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2018 |
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin | 2016 |
[Clostridium difficile infection : What is currently available for treatment?]
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Fidaxomicin; Humans; Megacolon, Toxic; Metronidazole; Treatment Outcome; Vancomycin | 2016 |
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; France; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Recurrence; Vancomycin | 2017 |
Lack of Benefit With Combination Therapy for Clostridium difficile Infection.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Length of Stay; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Electronic Data Processing; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Female; Hospital Information Systems; Humans; Laxatives; Male; Metronidazole; Middle Aged; Vancomycin | 2017 |
Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Disease Notification; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Length of Stay; Medical Records Systems, Computerized; Metronidazole; Practice Patterns, Physicians'; Telephone; Time Factors; Vancomycin | 2008 |
Clostridium difficile enteritis following total colectomy.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin | 2008 |
Clostridium difficile pancolitis in adults with cystic fibrosis.
Topics: Adult; Clostridioides difficile; Cystic Fibrosis; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Steroids; Vancomycin | 2008 |
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Culture Media; DNA Fingerprinting; Enterocolitis, Pseudomembranous; Genotype; Glycopeptides; Humans; Lipoglycopeptides; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Vancomycin | 2008 |
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Colony Count, Microbial; DNA, Bacterial; Enterocolitis, Pseudomembranous; Glycopeptides; Humans; In Vitro Techniques; Lipoglycopeptides; Microbial Viability; Polymerase Chain Reaction; Ribotyping; Spores, Bacterial; Vancomycin | 2008 |
Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2008 |
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin | 2008 |
A mouse model of Clostridium difficile-associated disease.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Disease Models, Animal; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Mice; Mice, Inbred C57BL; Severity of Illness Index; Vancomycin | 2008 |
[Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis].
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Middle Aged; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2008 |
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.
Topics: Candida; Candidiasis; Clostridioides difficile; Drug Resistance, Fungal; Enterococcus; Enterocolitis, Pseudomembranous; Hospitalization; Hospitals; Humans; Incidence; Infection Control; Medical Records; Methicillin; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin; Vancomycin Resistance | 2008 |
Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Clostridioides difficile; Enterococcus; Enterocolitis, Pseudomembranous; Environmental Microbiology; Equipment Contamination; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Skin; Vancomycin; Vancomycin Resistance | 2009 |
Management of Clostridium difficile infection--medical or surgical?
Topics: Anti-Bacterial Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 2008 |
In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Synergism; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2009 |
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Benzopyrans; Cell Line; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Male; Spores, Bacterial; Survival Analysis; Thiophenes; Vancomycin | 2009 |
[The approach to recurrent infections with Clostridium difficile].
Topics: Anti-Bacterial Agents; Brachytherapy; Clostridioides difficile; Combined Modality Therapy; Complementary Therapies; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin | 2008 |
Clostridium difficile-associated diarrhea in Crohn's disease patients with ostomy.
Topics: Adult; Clostridioides difficile; Colectomy; Crohn Disease; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Ostomy; Postoperative Complications; Prognosis; Vancomycin | 2010 |
Working out the bug in the accordion.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Colon; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Humans; Intestinal Mucosa; Male; Megacolon, Toxic; Middle Aged; Tomography, X-Ray Computed; Vancomycin | 2009 |
Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Gastrointestinal Tract; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Vancomycin | 2009 |
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Agents; Humans; Male; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome; Vancomycin | 2009 |
Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cultured Milk Products; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Probiotics; Secondary Prevention; Vancomycin | 2009 |
Clostridium difficile infection: historic review.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Female; Guinea Pigs; History, 20th Century; Humans; Metronidazole; Vancomycin; Young Adult | 2009 |
Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.
Topics: Acute Disease; Acute Kidney Injury; Administration, Oral; Aged; Anti-Bacterial Agents; Biological Availability; Drug Monitoring; Enterocolitis, Pseudomembranous; Hemodiafiltration; Humans; Male; Necrosis; Pancreatitis, Alcoholic; Severity of Illness Index; Vancomycin | 2009 |
Fluoroquinolone resistance and Clostridium difficile, Germany.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Ribotyping; Vancomycin | 2010 |
[Change of Clostridium difficile colitis during recent 10 years in Korea].
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Republic of Korea; Retrospective Studies; Vancomycin | 2010 |
Clostridium difficile enteritis 9 years after total proctocolectomy: a rare case report.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Colitis, Ulcerative; Enteritis; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Proctocolectomy, Restorative; Vancomycin | 2010 |
Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Clostridioides difficile; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Phenylalanine; Phenylpropionates; Schizophrenia; Sex Characteristics; Vancomycin; Young Adult | 2010 |
Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterococcus; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Quebec; Vancomycin; Vancomycin Resistance | 2010 |
Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; United States; Vancomycin; Young Adult | 2010 |
Community-acquired Clostridium difficile-associated diarrhea in a patient on chronic peritoneal dialysis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Peritoneal Dialysis; Vancomycin | 2010 |
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2010 |
Failure of tigecycline to treat severe Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Critical Care; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Treatment Failure; Vancomycin | 2010 |
Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Serum; Vancomycin | 2011 |
[A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas].
Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fever; Humans; Male; Neutropenia; Sigmoid Neoplasms; Vancomycin | 2010 |
'Game changer' antibiotic and others in works for superbug.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Secondary Prevention; Streptococcal Infections; United States; United States Food and Drug Administration; Vancomycin | 2011 |
Infection acquisition following intensive care unit room privatization.
Topics: Clostridioides difficile; Cohort Studies; Critical Care; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Hospital Design and Construction; Hospitals, University; Humans; Infection Control; Infections; Intensive Care Units; Interior Design and Furnishings; Methicillin-Resistant Staphylococcus aureus; Odds Ratio; Patients' Rooms; Quebec; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Lack of health insurance coverage for oral vancomycin: it's time to tackle the elephant in the room.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Insurance, Pharmaceutical Services; Medicare; United States; Vancomycin | 2011 |
Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals, Pediatric; Humans; Incidence; Inflammatory Bowel Diseases; Male; Metronidazole; Ohio; Retrospective Studies; Secondary Prevention; Vancomycin | 2011 |
Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Clostridioides difficile; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Risk Factors; Spinal Cord Injuries; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2011 |
Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Imipenem; Kidney Failure, Chronic; Male; Pneumonia; Vancomycin | 2011 |
Mouse relapse model of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Mice; Mice, Inbred C57BL; Secondary Prevention; Vancomycin | 2011 |
Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterococcus; Enterocolitis, Pseudomembranous; Feces; Female; Hemoglobins; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2011 |
Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Enterocolitis, Pseudomembranous; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Necrosis; Recovery of Function; Remission Induction; Tretinoin; Vancomycin | 2011 |
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Middle Aged; Vancomycin; Young Adult | 2011 |
Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colon; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Middle Aged; Odds Ratio; Pennsylvania; Polyethylene Glycols; Retrospective Studies; Severity of Illness Index; Survival Rate; Therapeutic Irrigation; Vancomycin | 2011 |
Reducing the risk of severe complications among patients with Clostridium difficile infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiprotozoal Agents; Comorbidity; Confusion; Enterocolitis, Pseudomembranous; Female; Humans; Hypotension; Leukocytosis; Male; Metronidazole; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Vancomycin | 2011 |
Antimicrobial use and risk for recurrent Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Metronidazole; Middle Aged; Minnesota; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Recognizing metronidazole resistant C. difficile.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin | 2011 |
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin | 2011 |
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin | 2012 |
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Enterobacteriaceae; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Intestines; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 2012 |
A novel agent effective against Clostridium difficile infection.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Disease Models, Animal; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Female; Humans; Morpholines; Nucleic Acid Synthesis Inhibitors; Purines; Vancomycin | 2012 |
Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Data Interpretation, Statistical; Drug Therapy, Combination; Endpoint Determination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Poisson Distribution; Prospective Studies; Risk; Sex Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Progress with a difficult infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Vancomycin | 2012 |
A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Drug Evaluation; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Vancomycin | 2012 |
Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metagenome; Recurrence; Surveys and Questionnaires; United States; Vancomycin | 2012 |
Evaluation of a hand-held far-ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens.
Topics: Clostridioides difficile; Colony Count, Microbial; Cross Infection; Decontamination; Disinfection; Drug Resistance; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Ultraviolet Rays; Vancomycin | 2012 |
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans | 2012 |
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Diarrhea; Endpoint Determination; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Polymers; Sulfonic Acids; Treatment Outcome; Vancomycin | 2012 |
Efficacy of LFF571 in a hamster model of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Recurrence; Thiazoles; Vancomycin | 2012 |
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Cricetinae; DNA Gyrase; DNA Topoisomerases, Type I; DNA-Directed DNA Polymerase; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Metronidazole; Mice; Nucleic Acid Synthesis Inhibitors; Species Specificity; Survival Rate; Topoisomerase II Inhibitors; Vancomycin; Weight Gain | 2012 |
In vitro and in vivo characterization of CB-183,315, a novel lipopeptide antibiotic for treatment of Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Mesocricetus; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 2012 |
[A case of pseudomembranous colitis concomitant with toxic megacolon and paralytic ileus].
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Intestinal Pseudo-Obstruction; Male; Megacolon, Toxic; Middle Aged; Vancomycin | 2012 |
In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Survival Rate; Vancomycin | 2012 |
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin | 2013 |
Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Recurrence; Treatment Outcome; Vancomycin | 2013 |
[Clostridium difficile associated diarrhea: reliable therapy with vancomycin capsules].
Topics: Aged; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Dysentery; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Risk Factors; Vancomycin | 2012 |
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Pneumatosis intestinalis in a patient with recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colic; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Pneumatosis Cystoides Intestinalis; Recurrence; Tomography, X-Ray Computed; Vancomycin | 2012 |
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.
Topics: Animals; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Female; Intestines; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microbial Consortia; Microbial Interactions; Molecular Sequence Data; Probiotics; Recurrence; Vancomycin | 2012 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
[Role of Clostridium difficile infection in the relapse of ulcerative colitis].
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Treatment Outcome; Vancomycin | 2002 |
[Antibiotic-associated diarrhea].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin | 2003 |
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Child, Preschool; Clostridioides difficile; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2003 |
Recurrent colitis with different causes.
Topics: Aged; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Enterocolitis, Pseudomembranous; Female; Humans; Pharyngitis; Risk Factors; Sulfasalazine; Vancomycin | 2003 |
Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.
Topics: Aged; Anti-Bacterial Agents; Colonoscopy; Decompression, Surgical; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin | 2003 |
Clostridium difficile infection in patients with unexplained leukocytosis.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leukocytosis; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin | 2003 |
[Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2003 |
Clostridium difficile colitis in children with cystic fibrosis.
Topics: Adolescent; Clostridioides difficile; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Humans; Male; Tomography, X-Ray Computed; Vancomycin | 2004 |
In-vitro activity of nisin against clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Nisin; Vancomycin | 2004 |
Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Kidney Transplantation; Male; Metronidazole; Middle Aged; Pancreas Transplantation; Risk Factors; Vancomycin | 2004 |
Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Enzyme-Linked Immunosorbent Assay; Mesocricetus; Microbial Sensitivity Tests; Rifamycins; Secondary Prevention; Survival Analysis; Vancomycin; Weight Loss | 2004 |
Pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2004 |
Colostomy with vancomycin administration as an effective treatment for toxic megacolon associated with fulminant pseudomembranous colitis: a case report.
Topics: Aged; Anti-Bacterial Agents; Colostomy; Enterocolitis, Pseudomembranous; Female; Humans; Megacolon, Toxic; Vancomycin | 2004 |
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2004 |
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Metronidazole; Prospective Studies; Treatment Failure; Vancomycin | 2005 |
Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2005 |
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Middle Aged; Quebec; Recurrence; Risk Factors; Treatment Failure; Vancomycin | 2005 |
Association of pseudomembranous colitis with Henoch-Schönlein purpura.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Clostridioides difficile; Colon; Colonoscopy; Enterocolitis, Pseudomembranous; Follow-Up Studies; Glucocorticoids; Humans; IgA Vasculitis; Male; Prednisolone; Vancomycin | 2005 |
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clindamycin; Clostridioides difficile; Cricetinae; Depsipeptides; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gastrointestinal Contents; Male; Random Allocation; Time Factors; Vancomycin | 2005 |
[Relapsing infections with Clostridium difficile].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cytotoxins; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 2005 |
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Lymphoma; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Autologous; Vancomycin | 2006 |
Severe diarrhea and shock.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Severity of Illness Index; Shock; Vancomycin | 2006 |
[Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Intestinal Mucosa; Vancomycin | 2006 |
Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
Topics: Absorption; Aged; Anti-Bacterial Agents; Colitis; Enterocolitis, Pseudomembranous; Female; Humans; Kidney; Vancomycin | 2006 |
Vancomycin-induced elevation of liver enzyme levels.
Topics: Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Vancomycin | 2006 |
[Occurrence and treatment of Clostridium difficile-associated diarrhea].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2006 |
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Community-Acquired Infections; Comorbidity; Databases, Factual; Drug Prescriptions; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin | 2006 |
Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Drug Prescriptions; Enterocolitis, Pseudomembranous; Humans; Odds Ratio; Proton Pump Inhibitors; Risk Factors; United Kingdom; Vancomycin | 2006 |
Management of an outbreak of Clostridium difficile-associated disease among geriatric patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Feces; Female; Geriatrics; HeLa Cells; Hospital Units; Humans; Incidence; Infection Control; Male; Metronidazole; Saccharomyces; Treatment Outcome; Vancomycin | 2006 |
Treatment of Clostridium difficile-associated disease (CDAD).
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2006 |
New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.
Topics: Brazil; Child; Child, Preschool; Clindamycin; Clostridioides difficile; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Ribotyping; Vancomycin | 2007 |
Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Disease Progression; Enterocolitis, Pseudomembranous; Hemoperfusion; Humans; Male; Middle Aged; Polymyxin B; Shock, Septic; Vancomycin | 2007 |
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
Topics: Adult; Age Factors; Aged; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
[Clostridium difficile associated diarrhea in the elderly patient].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2007 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
A case of recurrent Clostridium difficile diarrhea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin | 2007 |
Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Ribotyping; RNA, Bacterial; Singapore; Vancomycin | 2007 |
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Metronidazole; Quebec; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
The changing face of Clostridium difficile: what treatment options remain?
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Quebec; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cholecystitis; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Famotidine; Female; Humans; Metronidazole; Postoperative Complications; Vancomycin | 2007 |
Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Europe; Humans; Metronidazole; North America; Vancomycin | 2008 |
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Cross Infection; Enterococcus; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin; Vancomycin Resistance | 2008 |
Clostridium difficile infection.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Metronidazole; Risk Factors; Vancomycin | 2008 |
Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Vancomycin | 2008 |
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2008 |
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Kaplan-Meier Estimate; Metronidazole; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2008 |
[Postpartum pseudomembranous colitis].
Topics: Adult; Cefotaxime; Colon; Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Hysterectomy; Methylmethacrylates; Metronidazole; Obstetric Labor Complications; Pregnancy; Puerperal Disorders; Shock; Uterine Hemorrhage; Vancomycin | 1984 |
Vancomycin dose for pseudomembranous colitis.
Topics: Aged; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1980 |
Vancomycin dose for pseudomembranous colitis.
Topics: Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1980 |
Ampicillin-induced enterocolitis: implication of toxigenic Clostridium perfringens type C.
Topics: Ampicillin; Bacterial Toxins; Child; Clostridium Infections; Clostridium perfringens; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin | 1980 |
Is vancomycin overpriced?
Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1983 |
Pseudomembranous colitis after topical application of clindamycin.
Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1981 |
Treatment of antibiotic-associated colitis with vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Vancomycin | 1984 |
Spontaneous pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin | 1983 |
Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis.
Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; HLA Antigens; HLA-B27 Antigen; Humans; Male; Middle Aged; Osteoarthritis; Vancomycin | 1984 |
[Clostridium difficile].
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Toxins, Biological; Vancomycin | 1983 |
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin | 1984 |
Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.
Topics: Anuria; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Kidney; Male; Middle Aged; Vancomycin | 1984 |
Pseudomembranous colitis due to oxacillin therapy.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Oxacillin; Vancomycin | 1984 |
Fatal pseudomembranous colitis despite eradication of Clostridium difficile.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin | 1981 |
Antibiotic-associated colitis--the continuing saga.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1981 |
Non-Clostridium difficile pseudomembranous colitis responding to both vancomycin and metronidazole. ?
Topics: Adolescent; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Vancomycin | 1981 |
Metronidazole and antibiotic-associated colitis.
Topics: Aged; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Vancomycin | 1981 |
Antibiotic-associated pseudomembranous colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Guinea Pigs; Humans; Intestines; Staphylococcal Infections; Vancomycin | 1981 |
Vancomycin: a reappraisal.
Topics: Clostridium Infections; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Humans; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1982 |
Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Ischemia; Vancomycin | 1982 |
Absorption of oral vancomycin - possible associated toxicity.
Topics: Administration, Oral; Adolescent; Brain Diseases; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Fever; Humans; Vancomycin | 1983 |
An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy?
Topics: Clostridium Infections; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Vancomycin | 1983 |
Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases.
Topics: Adult; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 1983 |
Bacitracin therapy in antibiotic-associated pseudomembranous colitis.
Topics: Adult; Ampicillin; Bacitracin; Cephalosporins; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Male; Penicillin Resistance; Urinary Tract Infections; Vancomycin | 1980 |
[Pseudomembranous colitis: observations on 13 clinical cases].
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Loperamide; Male; Metronidazole; Middle Aged; Neomycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1981 |
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Recurrence; Vancomycin | 1980 |
Antibiotic-associated pseudomembranous colitis: 1980.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Cricetinae; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
Metronidazole: an alternate therapy for antibiotic-associated colitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1982 |
Treatment of recurrent antibiotic-associated pseudomembranous colitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin | 1982 |
[Vancomycin: treatment of staphylococcal septicemias and pseudomembranous colitis].
Topics: Enterocolitis, Pseudomembranous; Humans; Sepsis; Staphylococcal Infections; Vancomycin | 1982 |
Pseudomembranous colitis unresponsive to oral vancomycin therapy.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Vancomycin | 1982 |
Diarrhea we can treat: antibiotic-associated colitis.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1982 |
Clostridium difficile: the epidemiology and prevention of hospital-acquired infection.
Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Equipment and Supplies, Hospital; Feces; Humans; Vancomycin | 1982 |
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Middle Aged; Vancomycin | 1982 |
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Metronidazole; Recurrence; Vancomycin | 1981 |
Pseudomembranous colitis.
Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin | 1980 |
Case report. Clindamycin associated pseudomembranous colitis.
Topics: Child; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin | 1981 |
A second relapse of Clostridium difficile colitis.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1981 |
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters.
Topics: Animals; Clostridium; Clostridium Infections; Colitis; Cricetinae; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Mesocricetus; Vancomycin | 1981 |
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
Topics: Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Recurrence; Vancomycin | 1981 |
Antibiotic-associated pseudomembranous colitis in children.
Topics: Administration, Oral; Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Infant; Male; Penicillin G; Vancomycin | 1981 |
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1981 |
Survival after necrotizing enterocolitis of leukemia treated with oral vancomycin.
Topics: Administration, Oral; Enterocolitis, Pseudomembranous; Female; Humans; Leukemia, Lymphoid; Middle Aged; Vancomycin | 1981 |
Antibiotic-associated colitis--an abating enigma.
Topics: Anti-Bacterial Agents; Bacitracin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Lincomycin; Metronidazole; Vancomycin | 1981 |
Nonantibiotic-associated enterocolitis caused by Clostridium difficile in an infant.
Topics: Biopsy; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Jejunum; Vancomycin | 1981 |
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
Topics: Absorption; Animals; Anion Exchange Resins; Anti-Bacterial Agents; Binding, Competitive; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Cricetinae; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Feces; Ion Exchange Resins; Male; Vancomycin | 1980 |
The response of pseudomembranous colitis to vancomycin.
Topics: Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Middle Aged; Recurrence; Vancomycin | 1980 |
Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1980 |
Relapse of antibiotic-associated colitis after vancomycin therapy.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
Antibiotic-associated pseudomembranous colitis: pathogenesis and management.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridium; England; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Prospective Studies; Vancomycin | 1980 |
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cholestyramine Resin; Clostridium Infections; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rabbits; Vancomycin | 1980 |
Antibiotic-induced colitis.
Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
Oxacillin-induced pseudomembranous colitis.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Oxacillin; Staphylococcal Infections; Vancomycin | 1980 |
Vancomycin therapy for Clostridium difficile.
Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Recurrence; Vancomycin | 1980 |
Vancomycin therapy Clostridium difficile.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
Relapse of Clostridium colitis after vancomycin therapy.
Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1980 |
[Carcinoembryonic antigen in a case of pseudomembraneous colitis].
Topics: Aged; Carcinoembryonic Antigen; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1980 |
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis.
Topics: Animals; Anti-Bacterial Agents; Cecal Diseases; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammation; Intestines; Male; Patient Isolation; Vancomycin | 1980 |
Clinical and laboratory observations in Clostridium difficile colitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Cricetinae; Cytotoxins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Guinea Pigs; Vancomycin | 1980 |
[Antibiotic-induced pseudomembranous colitis].
Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1980 |
[Peroral vancomycin for antibiotic-related pseudomembraneous colitis].
Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
[Pseudomembranous entercolitis after antibiotic treatment: vancomycin therapy].
Topics: Amoxicillin; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Male; Otitis Media; Vancomycin | 1980 |
Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin.
Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1980 |
Vancomycin pharmacokinetics and dosing in premature neonates.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Sepsis; Staphylococcal Infections; Vancomycin | 1995 |
Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea.
Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Recurrence; Saccharomyces cerevisiae; Vancomycin | 1995 |
Systemic absorption of vancomycin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Middle Aged; Vancomycin | 1995 |
[Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ascitic Fluid; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Norfloxacin; Vancomycin | 1995 |
[5 cases of clostridium difficile enteritis in infants].
Topics: Child; Child, Preschool; Enterocolitis, Pseudomembranous; Erythromycin; Female; Humans; Male; Prognosis; Vancomycin | 1995 |
Pseudomembranous colitis in a patient with a colostomy.
Topics: Cephalexin; Colonoscopy; Colostomy; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.
Topics: Administration, Oral; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Hospitals, Veterans; Humans; Metronidazole; Minnesota; Population Surveillance; Prospective Studies; Vancomycin | 1994 |
[Combatting nosocomial intestinal infections with yeasts].
Topics: Combined Modality Therapy; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Saccharomyces; Vancomycin; Yeast, Dried | 1995 |
Clostridium difficile colitis: an increasing hospital-acquired illness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin | 1995 |
Cefixime and antibiotic-associated colitis.
Topics: Cefixime; Cefotaxime; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 1994 |
[Clostridium difficile in early childhood ulcerative pancolitis].
Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Male; Prednisone; Recurrence; Sulfasalazine; Vancomycin | 1993 |
Systemic absorption after local intracolonic vancomycin in pseudomembranous colitis.
Topics: Acute Kidney Injury; Enterocolitis, Pseudomembranous; Hemofiltration; Humans; Intestinal Absorption; Vancomycin | 1993 |
Clostridium difficile colitis.
Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1994 |
Clostridium difficile colitis.
Topics: Clostridioides difficile; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Risk Factors; Vancomycin | 1994 |
Clostridium difficile after haemolytic uraemic syndrome.
Topics: Adolescent; Child; Child, Preschool; Clostridioides difficile; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Male; Vancomycin | 1993 |
Intracolonic vancomycin for pseudomembranous colitis.
Topics: Aged; Aged, 80 and over; Enterocolitis, Pseudomembranous; Humans; Intestinal Pseudo-Obstruction; Intubation, Gastrointestinal; Male; Vancomycin | 1993 |
Antibiotic-associated pseudomembranous colitis with toxic megacolon after cesarean section.
Topics: Adult; Anti-Bacterial Agents; Cesarean Section; Enterocolitis, Pseudomembranous; Female; Humans; Megacolon, Toxic; Postoperative Complications; Vancomycin | 1993 |
Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
Topics: Adult; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Male; Metronidazole; Vancomycin | 1993 |
Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Chi-Square Distribution; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Leukocyte Count; Male; Metronidazole; Vancomycin | 1993 |
[Toxic megacolon in pseudomembranous colitis. Complicated course of antibiotic-induced Clostridium difficile colitis].
Topics: Adolescent; Clindamycin; Combined Modality Therapy; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Male; Megacolon, Toxic; Sigmoidoscopy; Sinusitis; Vancomycin | 1993 |
Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy.
Topics: Aged; Aged, 80 and over; DNA, Bacterial; Enterococcus faecium; Enterocolitis, Pseudomembranous; Feces; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin | 1995 |
The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 1996 |
Acute flexor tenosynovitis in association with Clostridium difficile infection: a case report.
Topics: Adult; Amoxicillin; Arthritis, Infectious; Clostridioides difficile; Combined Modality Therapy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Infant, Newborn; Otitis Media; Pregnancy; Pregnancy Complications, Infectious; Quadriplegia; Tenosynovitis; Vancomycin | 1996 |
Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.
Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Female; Humans; Immunoblotting; Recurrence; Vancomycin | 1996 |
[Occurrence and clinical picture of Clostridium difficile infections after antibiotic therapy].
Topics: Adult; Anti-Bacterial Agents; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1995 |
Pseudomembranous colitis.
Topics: Administration, Oral; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1996 |
[A case of pseudomembranous enterocolitis which diagnosis was delayed in the outpatient clinic].
Topics: Aged; Ambulatory Care; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin | 1997 |
Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Metronidazole; Vancomycin | 1997 |
[Complicated amebic liver abscess--course and therapy].
Topics: Combined Modality Therapy; Cytomegalovirus Infections; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Escherichia coli O157; Feces; Gastrointestinal Hemorrhage; Humans; Liver Abscess, Amebic; Male; Middle Aged; Opportunistic Infections; Postoperative Complications; Pulmonary Atelectasis; Respiratory Insufficiency; Tomography, X-Ray Computed; Travel; Vancomycin | 1997 |
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
Topics: Acute Disease; Bacteremia; Clostridioides difficile; Cohort Studies; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Neutropenia; Risk Factors; Vancomycin | 1997 |
Fulminant pseudomembranous colitis leading to total colonic stricture.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Colectomy; Colonic Diseases; Constriction, Pathologic; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Ileostomy; Metronidazole; Proctocolectomy, Restorative; Rectal Diseases; Vancomycin | 1997 |
Pseudomembraneous clostridium after autologous bone marrow transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bone Marrow Transplantation; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hematopoiesis; Hodgkin Disease; Humans; Male; Metronidazole; Transplantation, Autologous; Vancomycin | 1998 |
[Clostridium difficile toxin-associated diarrhea in geriatrics].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Frail Elderly; Humans; Male; Risk Factors; Vancomycin | 1998 |
Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Community; Humans; Incidence; Poisson Distribution; Thermometers; United States; Vancomycin | 1998 |
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Linear Models; Male; Metronidazole; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Time Factors; Treatment Failure; Vancomycin | 1998 |
Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Vancomycin | 1999 |
The hunt for Clostridium difficile: 21-year follow-up of a stool specimen sent for culture.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Penicillins; Vancomycin | 1999 |
Clostridium difficile splenic abscess.
Topics: Abscess; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Middle Aged; Splenic Diseases; Vancomycin | 2000 |
Systemic vancomycin overexposure in a patient with spinal cord injury who had Staphylococcal sepsis and Clostridium difficile colitis.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Monitoring; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Spinal Cord Injuries; Staphylococcal Infections; Vancomycin | 2000 |
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin | 2000 |
[Recurrent Clostridium difficile enterocolitis].
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunoglobulins, Intravenous; Metronidazole; Recurrence; Saccharomyces; Vancomycin | 2000 |
Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain. Recurring C. difficile infection.
Topics: Abdominal Pain; Adult; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Male; Metronidazole; Vancomycin | 2001 |
Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis.
Topics: Aged; Anti-Bacterial Agents; Colonoscopy; Decompression, Surgical; Enterocolitis, Pseudomembranous; Feasibility Studies; Humans; Instillation, Drug; Male; Middle Aged; Treatment Outcome; Vancomycin | 2001 |
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diverticulum, Colon; Enema; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin | 2001 |
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin | 2002 |
Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
Topics: Administration, Rectal; Adult; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Opportunistic Infections; Vancomycin | 2002 |
Incidence of pseudomembranous colitis after vancomycin-treated MRSA infection.
Topics: Brain Neoplasms; Clostridioides difficile; Critical Care; Enterocolitis, Pseudomembranous; Fatal Outcome; Humans; Incidence; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2002 |
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; HIV Infections; Humans; Metronidazole; Microbial Sensitivity Tests; Time Factors; Vancomycin | 2002 |
Value of Clostridium difficile antigen test in immunocompromised hosts in the tropics.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Immunocompromised Host; Tropical Climate; Vancomycin | 1991 |
Vancomycin for antibiotic-induced colitis.
Topics: Adult; Ampicillin; Colon, Sigmoid; Enterocolitis, Pseudomembranous; Humans; Male; Proctitis; Vancomycin | 1978 |
Vancomycin for pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Vancomycin | 1978 |
Oral vancomycin for antibiotic-associated pseudomembranous colitis.
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefazolin; Clindamycin; Enterocolitis, Pseudomembranous; Feces; Humans; Penicillins; Vancomycin | 1978 |
Anion-exchange resins in pseudomembranous colitis.
Topics: Anion Exchange Resins; Binding Sites; Cholestyramine Resin; Colestipol; Drug Evaluation; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; In Vitro Techniques; Intestinal Absorption; Ion Exchange Resins; Polyamines; Vancomycin | 1978 |
Relapse of pseudomembranous colitis after vancomycin therapy.
Topics: Administration, Oral; Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin | 1979 |
Comparison of five regimens for treatment of experimental clindamycin-associated colitis.
Topics: Animals; Antitoxins; Clindamycin; Clostridium perfringens; Colestipol; Cricetinae; Drug Evaluation; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Methylprednisolone; Polyamines; Tetracycline; Vancomycin | 1978 |
Therapy of antibiotic-associated pseudomembranous colitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Retrospective Studies; Vancomycin | 1979 |
Relapse of pseudomembranous colitis after vancomycin therapy.
Topics: Administration, Oral; Adult; Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Recurrence; Time Factors; Vancomycin | 1979 |
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin | 1979 |
Antibiotic susceptibility of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Miconazole; Microbial Sensitivity Tests; Vancomycin | 1979 |
[Antibiotic-induced pseudomembranous Clostridium difficile colitis. A new etiopathogenetically definable infectious disease].
Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Feces; Guinea Pigs; Humans; Metronidazole; Vancomycin | 1979 |
Antibiotic-associated colitis--a review of 66 cases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Vancomycin | 1979 |
Antibiotic-associated colitis treated with oral vancomycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Female; Humans; Male; Staphylococcal Infections; Vancomycin | 1979 |
Antibiotic-associated pseudomembranous colitis. Rapid clinical response to oral vancomycin.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Vancomycin | 1979 |
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.
Topics: Animals; Autopsy; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Colitis; Colon; Diarrhea; DNA; Enterocolitis, Pseudomembranous; Ileitis; Intestinal Mucosa; Male; Rabbits; Vancomycin | 1978 |
Antibiotic-associated colitis: report of a case.
Topics: Amikacin; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Injections, Intraperitoneal; Kanamycin; Male; Middle Aged; Peritonitis; Vancomycin | 1978 |
Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.
Topics: Aged; Animals; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Diabetes Complications; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leg Ulcer; Lincomycin; Vancomycin | 1978 |
[Pseudo-membranous colitis: effective treatment with vancomycin].
Topics: Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Remission, Spontaneous; Vancomycin | 1978 |
Clindamycin-induced colitis.
Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin | 1979 |
Clindamycin-associated colitis in hamsters: protection with vancomycin.
Topics: Animals; Clindamycin; Colon; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gentamicins; Lincomycin; Male; Vancomycin | 1977 |
The protective effect of vancomycin on clindamycin-induced colitis in hamsters.
Topics: Administration, Oral; Animals; Clindamycin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Injections, Subcutaneous; Intestines; Male; Vancomycin | 1977 |
Death from pseudomembranous enterocolitis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Castration; Cephalothin; Cesarean Section; Enterocolitis, Pseudomembranous; Fallopian Tubes; Female; Humans; Hysterectomy; Kanamycin; Methicillin; Middle Aged; Postoperative Complications; Pregnancy; Vancomycin | 1975 |
Pseudomembranous colitis following resection for Hirschsprung's disease.
Topics: Administration, Rectal; Child, Preschool; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Female; Hirschsprung Disease; Humans; Intestinal Mucosa; Male; Metronidazole; Postoperative Complications; Reoperation; Vancomycin | 1992 |
Ask the Pharmacist.
Topics: Cholestyramine Resin; Colestipol; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1992 |
Pseudomembranous enteritis: rediscovery of a previously well-described entity?
Topics: Adult; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1992 |
[The diagnosis and treatment of Clostridium difficile enterocolitis].
Topics: Adult; Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Vancomycin | 1991 |
[A lethal course in pseudomembranous enterocolitis during the parenteral administration of vancomycin and imipenem].
Topics: Colon; Combined Modality Therapy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Imipenem; Infusions, Intravenous; Middle Aged; Postoperative Complications; Vancomycin | 1992 |
[Clinical study of pseudomembranous colitis: a neurosurgical viewpoint].
Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Cerebral Hemorrhage; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Postoperative Complications; Vancomycin | 1990 |
Pseudomembranous colitis: how useful is endoscopy?
Topics: Colonoscopy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Sigmoidoscopy; Vancomycin | 1990 |
Antibiotic-associated pseudomembranous colitis.
Topics: Administration, Oral; Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Metronidazole; Vancomycin | 1990 |
Inappropriate antibiotic use and the development of Clostridium difficile colitis.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 1990 |
[Antibiotic associated diarrhea].
Topics: Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1990 |
[Pseudomembranous colitis caused by antibiotic therapy during aorto-iliac surgery].
Topics: Aorta, Abdominal; Blood Vessel Prosthesis; Cholestyramine Resin; Enterocolitis, Pseudomembranous; Humans; Iliac Artery; Metronidazole; Vancomycin | 1990 |
Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Vancomycin | 1989 |
Cost-effective treatment of pseudomembranous colitis.
Topics: Cost-Benefit Analysis; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Prospective Studies; Random Allocation; Vancomycin | 1989 |
Treatment of Clostridium difficile diarrhea.
Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1989 |
Vancomycin for pseudomembranous colitis.
Topics: Costs and Cost Analysis; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1989 |
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cricetinae; Daptomycin; Disease Models, Animal; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin | 1987 |
LY146032 treatment of Clostridium difficile colitis in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Daptomycin; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin | 1987 |
Chlorpropamide-induced cholestatic jaundice and pseudomembranous colitis.
Topics: Chlorpropamide; Cholestasis; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Male; Middle Aged; Radiography; Sigmoidoscopy; Sulfasalazine; Sulfonamides; Vancomycin | 1985 |
Clostridium difficile colitis secondary to intravenous vancomycin.
Topics: Aged; Enterocolitis, Pseudomembranous; Humans; Male; Osteomyelitis; Vancomycin | 1989 |
Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Glycopeptides; Humans; Teicoplanin; Vancomycin | 1985 |
[Antibiotic-associated colitis and Clostridium difficile].
Topics: Adult; Aged; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Vancomycin | 1985 |
Combined medical and surgical management of severe pseudomembranous colitis.
Topics: Combined Modality Therapy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Infant; Intestinal Obstruction; Male; Vancomycin | 1988 |
Oral vancomycin in prevention of necrotising enterocolitis.
Topics: Administration, Oral; Enterocolitis, Pseudomembranous; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Vancomycin | 1988 |
Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.
Topics: Carrier State; Clostridium; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Hospital Units; Humans; Leukemia; Prospective Studies; Serotyping; Vancomycin | 1987 |
Clostridium difficile colitis following treatment with metronidazole and vancomycin.
Topics: Adult; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Opportunistic Infections; Vancomycin | 1987 |
Clostridium difficile colitis induced by cytarabine.
Topics: Aged; Cytarabine; Enterocolitis, Pseudomembranous; Humans; Leukemia, Myeloid; Male; Vancomycin | 1987 |
CT-guided percutaneous catheter cecostomy.
Topics: Aged; Catheterization; Cecum; Enterocolitis, Pseudomembranous; Evaluation Studies as Topic; Female; Humans; Methods; Tomography, X-Ray Computed; Vancomycin | 1987 |
Vancomycin-induced pseudomembranous colitis.
Topics: Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin | 1987 |
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.
Topics: Animals; Bacterial Proteins; Bacterial Toxins; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Latex Fixation Tests; Recurrence; Saccharomyces; Vancomycin | 1987 |
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1987 |
Pseudomembranous colitis: local experience with 3 cases.
Topics: Aged; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Sigmoidoscopy; Vancomycin | 1986 |
Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis.
Topics: Ampicillin; Anti-Bacterial Agents; Birth Weight; Cefotaxime; Clinical Protocols; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Gentamicins; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Vancomycin | 1987 |
Pseudomembranous colitis & antibiotics.
Topics: Cefoxitin; Enema; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin | 1986 |
Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Child; Child, Preschool; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Vancomycin | 1986 |
Vancomycin and necrotising enterocolitis.
Topics: Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Intestinal Absorption; Vancomycin | 1986 |
[Relapsing pseudomembranous colitis in uremia].
Topics: Cefotaxime; Cholestyramine Resin; Clindamycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Uremia; Vancomycin | 1986 |
A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Motility; Humans; Infant; Male; Middle Aged; Risk; Vancomycin | 1986 |
Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section.
Topics: Adult; Cesarean Section; Clostridium; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Postoperative Complications; Pregnancy; Vancomycin | 1985 |
Antibiotic-associated pseudomembranous colitis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin | 1985 |
Pseudomembranous colitis in spinal cord injury.
Topics: Adult; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Male; Quadriplegia; Spinal Cord Injuries; Vancomycin; Wounds, Gunshot | 1985 |
Clostridium difficile colitis following head and neck surgery. Report of cases.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Head and Neck Neoplasms; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Vancomycin | 1985 |
[Increasing incidence of pseudomembranous colitis and its association with antibiotic therapy].
Topics: Clindamycin; Enterocolitis, Pseudomembranous; Humans; Israel; Postoperative Complications; Surgical Procedures, Operative; Vancomycin | 1985 |
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridium; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Recurrence; Spores, Bacterial; Vancomycin | 1985 |
Clostridium difficile colitis associated with single-dose cefazolin prophylaxis.
Topics: Adult; Cefazolin; Cesarean Section; Enterocolitis, Pseudomembranous; Female; Humans; Pregnancy; Premedication; Vancomycin | 1985 |
Clostridium difficile-associated colitis in uremic patients.
Topics: Adult; Aged; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Uremia; Vancomycin | 1985 |
[Studies on the hamster colitis model].
Topics: Animals; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Female; Gentamicins; Male; Mesocricetus; Penicillin G; Vancomycin | 1985 |
Staphylococcic (pseudomembranous) enterocolitis.
Topics: Enterocolitis, Pseudomembranous; Humans; Staphylococcal Infections; Vancomycin | 1966 |
Staphylococcal enterocolitis--treatment with oral vancomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Staphylococcal Infections; Vancomycin | 1966 |